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SUMMARY
Selective decontamination of the digestive tract (SDD) uses orally 
administered antibiotics to eliminate or markedly reduce the number of aerobic 
gram-negative bacilli colonizing the digestive tract, thus preventing 
endogenous infection with these organisms. The selective activity of the drugs 
used allows retention of the normally predominant anaerobic flora of the tract, 
thus preventing overgrowth or colonization with organisms resistant to the 
decontaminating agents; this phenomenon is termed "colonization resistance" 
(CR). SDD has been increasingly applied to medico-surgical intensive care 
patients, a procedure that remains highly contentious.
The concept of colonization resistance is central to the use of SDD. 
However, the mechanisms underlying this phenomenon are both complex and 
disputed. Further, the experimental basis for the clinical use of SDD is 
dependentto a surprising degree on a restricted series of studies involving total 
decontamination of the digestive tract of mice carried out by van der Waaij and 
colleagues between 1971 and 1974.
This thesis described studies in two areas. First, repetition of the total 
decontamination studies of van der Waaij et al., (1971) in order to verify or 
modify their conclusions concerning colonization resistance. Second, the 
application of the same mouse model to the SDD regimen most commonly 
used in clinical ITU practice: orally administered mixture of polymyxin E, 
tobramycin, and amphotericin B (PTA) with or without the addition of 
systemically administered cefotaxime.
Treated and untreated Balb / c mice were subjected to direct oral 
challenge with bacteria resistant to the decontaminating agents, together with 
detailed microbiological monitoring of the aerobic and anaerobic faecal flora. 
Throughout these studies the results were greatly influenced by the details of
the technique employed.
Untreated, control mice showed a very high CR. A challenge dose of
10810 cfu of E. coli S-R21 was required to achieve colonization in 50 % of mice, 
and 6 other challenge strains (Klebsiella pneumoniae S-R10, Pseudomonas 
aeruginosa S-R321, Proteus mirabilis s-R9, Pseudomonas cepacia S-R13, 
Providencia stuartii s-R7 and Candida albicans s-R5) failed to colonize the 
control mice at a maximum test dose of 10a 10 cfu.
TDD rapidly reduced the aerobic faecal flora to undetectable levels. A 
marked reduction in the numbers and diversity of anaerobic flora was also seen, 
but this effect was more variable and often incomplete. These changes were 
associated with a striking reduction in the CR for E.coli S-R21. Values of < 2 
were obtained, together with extensive multiplication of the challenge in the 
gut of mice. However, there was a marked variation in the CR results with 
different challenge organisms.
SDD rapidly eliminated indigenous E.coli from the faeces, but had little 
effect on the levels of enterococci. Effects on anaerobic flora were limited to 
some simplification in flora diversity. A small reduction in CR was noted in these 
mice, but this was much less than that seen with TDD and multiplication of the 
challenge organisms within the gut was not observed.
Treatment with systemic cefotaxime alone was associated with 
elimination of faecal E.coli and overgrowth with enterococci. There was also a 
major reduction in the diversity of anaerobic flora, although the total viable 
count was unchanged. These changes were not associated with a significant 
reduction in CR.
However, SDD supplemented with systemic cefotaxime produced 
striking and surprising results. As previously, E.coli was rapidly eliminated, but 
this was accopanied by a marked overgrowth with enterococci. In addition,
xxii
there was either apparent elimination of anaerobic flora or a marked reduction 
in both the numbers and the diversity of these organisms. These changes were 
associated with a marked reduction in CR (to value < 4, the smallest challenge 
tested). These results are surprising in view of the clinical experience with this 
widely used regimen. They also give rise to clinical concern and they warrant 
further investigation.
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Chapter One
INTRODUCTION
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1. INTRODUCTION
1.1 What is Selective Decontamination of the Digestive Tract?
Selective decontamination of the digestive tract (SDD) is a drug 
regimen designed to allow the use of antimicrobials for prophylaxis of 
infection in seriously ill patients, without incurring problems of drug 
resistance. Non-absorbed drugs are administered orally to selectively 
eliminate aerobic gram-negative bacilli, and yeasts from the digestive tract, 
thus removing a major source of endogenous infection. The highly selective 
activity of the drugs used allows retention of the normally predominant 
anaerobic flora and this ( together with other factors) prevents outgrowth 
or colonisation with strains resistant to the decontamination agents (van der 
Waaij et al., 1971; van Saene and Stoutenbeek, 1987; Ledingham etal.,
1988).
SDD has been employed in patients suffering from neutropenia, in the 
medico-surgical intensive care unit ( ICU ), and in patients undergoing liver 
transplantation (Tetteroo et al., 1990; Wiesner, 1990) and marrow 
transplantation (Heimdahl, 1984). For convenience these patients will be 
described hereafter as the SDD patient group. There is a very high 
incidence of infection in this patient group (Kunin et al., 1973; Thorp etal., 
1979; Haley et al., 1981; Stevens et al., 1981; van der Waaij, 1982; Guglie et 
al., 1983; Cruse, 1986; Eikhoff, 1986; Kaiser, 1986; Milatovic and Braveny, 
1987; Potgieteretal., 1987; Platt, etal., 1990); the incidence of infection may 
exceed 80% in ICU patients admitted for more than five days (Thorp et al., 
1979; Kerver et al., 1987). In addition, most of the infection episodes 
display a characteristic pattern of pathogenic mechanisms that are central 
to the application of SDD as a prophylactic measure.
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1.2 Pattern of Pathogenesis in the SDD Patient Group:
These patients usually have significant and often very major 
impairment of host defences. Infections are managed in hospitals and they 
can be caused by both community, or hospital-acquired microorganisms. 
However hospital-acquired infections represent the major problem. The 
distinction between hospital and community acquired infection may be 
difficult. By convention, infections diagnosed on admission to the hospital 
and up to 48 hours thereafter are usually assumed to be caused by 
community microorganisms and subsequent infections are assumed to be 
hospital acquired.
A wide range of organisms is associated with infection. However, 
there is a marked predominance of coliform bacilli (particularly Escherichia 
coli, Klebsiella, Proteus, Enterobacter, Serratia), Pseudomonas aeruginosa, 
and, less commonly, Acinetobacter species (Northeyetal., 1974; Dummer 
et al., 1983; Pptgieter et al., 1987; Ledingham et al., 1988). In the present 
context, the term aerobic gram-negative bacilli (AGNB) is a useful collective 
term forthis group of organisms (Alcock, 1990). In addition to AGNB, yeasts 
( usually Candida albicans) are also a significant cause of infection in these 
patients (Gaya et al., 1973; Thorp et al., 1979; Potgieter et al., 1987). This 
predominance of AGNB and yeasts is particularly true of hospital-acquired 
infection.
Infection in the SDD patient group may be further classified as 
exogenous or endogenous. This distinction is necessarily somewhat 
arbitrary, but it has considerable practical application.
An exogenous infection is caused by organisms that are acquired from 
outside the patient (Sanderson, 1989; Stoutenbeek, 1989: Stoutenbeek and
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van Saene, 1990), and that are seeded directly to the site of infection (e.g. a 
wound). It was once assumed that hospital-acquired infections were mainly 
exogenous, acquired directly or indirectly from other patients, food (Shooter 
etal., 1969; Cooke etal., 1970; Pasch, 1974), attendants, staff, environment 
(Sanderson, 1989), or equipment (Stoutenbeek, 1989).
Endogenous infection is caused by the patients own body flora 
(normal or abnormal), and the most important sites have been identified as 
the oropharynx, stomach, intestine, and skin (van Saene etal., 1983; Kerver 
et al., 1987). Colonization of these sites with AGNB and yeasts are now 
believed to create a major source of infection in the SDD patient group 
(Ravin and Fine, 1962; Woodruff etal., 1973; van der Waaij, 1982; van Saene 
et al., 1983; Kerver et al., 1987; Deitch, 1988). Depending on the time 
occurrence, endogenous infections can be classified either as primary or 
secondary endogenous infections.
A primary endogenous infection is caused by organisms which the 
patient carries at the time of admission to the hospital. Overgrowth of these 
organisms, and colonization of abnormal sites may occur after admission 
(Stoutenbeek and van Saene, 1990; van Saene and Stoutenbeek, 1991). The 
major importance of the respiratory tract, and the digestive tract as a source 
of primary endogenous infections has been repeatedly demonstrated in liver 
transplantation (Tetterooetal., 1990; Wiesner, 1990), marrow transplantation 
(Heimdahl et al., 1894), granulocytopenic patients with cancer or leukemia 
(Tancrede and Andermont, 1985), and ITU patients (Thorp et al., 1979; 
Pptgieteretal., 1987).
A secondary endogenous infection is caused by organisms that 
colonize the patient after hospital admission. They are thus of initially 
exogenous origin and frequently involve hospital strains (Stoutenbeek,
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1989). However, after acquisition, proliferation of the these microorganisms 
(particularly in the oropharynx and gastrointestinal tra c t) is an essential 
prerequisite for endogenous infection elsewhere.
Secondary endogenous infections, usually develop after several 
days of admission (Stoutenbeek and van Saene, 1990; van Saene and 
Stoutenbeek, 1991). Aerobic gram negative bacilli are the principal 
organisms involved. These are hospital strains and frequently show 
resistance to many antibiotics (Abrams and Bishop, 1966; Schimpff et al., 
1972; van der Waaij and de Vries-Berghuis 1974; van der Waaij, 1982; 
Mulligan etal., 1984; Nord, 1984; Stoutenbeek, 1989). This abnormal pattern 
of colonization with indigenous, and acquired organisms not only 
predispose to endogenous infections, but also provides a novel source for 
further exogenous spread.
Colonizing microorganisms may contaminate internal tissues (and 
hence initiate endogenous infection) by three main routes:-
I. Direct contamination of wounds, skins, catheters, and vascular
lines.
II. Ventilated patients are particularly likely to suffer from lower 
respiratory tract infections. Most of these infections are now thought to be 
endogenous and involve AGNB. There is considerable evidence to indicate 
that these organisms are derived from the abnormal colonization of the 
stomach , and the oropharynx, and that in many cases this probably 
represents progression of colonization from the stomach to the oropharynx 
to the lower respiratory tract (Atherton and White, 1978; Chow et al., 1979; 
Daschneretal., 1982; Du Moulin etal., 1982; Ufflenetal., 1984; Maki, 1989)
III. Translocation: Under normal circumstances the intestinal 
mucosa functions as a major local defence barrier that prevents bacteria and
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endotoxin contained within the intestinal lumen from reaching systemic 
organs and tissue (Deitch, 1990). However, under certain circumstances, as 
in neutropenic or in immunocompromised patients, intestinal bacteria can 
escape from the gut and cause infections (Deitch, 1988). This process of 
intestinal bacteria invading extraintestinal tissue has been termed" bacterial 
translocation " (Deitch, 1988). Transient bacterial translocation probably 
occurs in normality with no ill effects. It appears that one or more of three 
basic pathophysiological factors are necessary for bacterial translocation to 
initiate infection.
1) Disruption in the balance of the normal intestinal microbial flora resulting in 
bacterial overgrowth with certain bacteria (especially AGNB) (van der Waaij et 
al., 1971,1977; van der Waaij, 1984).
2) Impaired host immune defences (Deitch, 1990).
3) Physical or physiological disruption of mucosal barrier function , as after 
treatment with cytotoxic drugs.
One or more of these factors frequently occur in the SDD Patients 
Group. It is hypothesized, therefore, that translocation may be an important 
factor in infections of endogenous origin in these patients (Deitch, 1990).
1.3 Therapeutic Response To Prevent Infection:
Considerable attempts have been made to prevent these types of 
hospital infections (Stoutenbeek et al., 1984; Unertl et al., 1987; Kerver et al., 
1988; Konrad et al., 1988; Ledingham et al., 1988; Aerdts et al., 1989; 
Crockerilletal., 1989; Guillaume etal., 1989; Thulig etal., 1989).
1) Considerable control over exogenous infections can be exercised 
by strict implementation of the center for disease control (CDC) guidelines 
Makietal., 1982). These guidelines concern the disinfection of wounds, an$ 
sterilization of equipment ( e.g. catheter and line policies used around the
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patients) and include measures to reduce the transmission from patient to 
patient by nursing techniques and discipline (CDC, 1985, Atlanta, Georgia, 
USA). These extensive procedures have shown appreciable success in 
preventing exogenous infection. However, in modern hospitals, and against 
the background of these practices, endogenous rather than exogenous 
transmission is now the major problem in the SDD Patient Group.
2) Systemic antibiotics have been used to prevent infection. These 
systemic antibiotics are active against organisms seeded internally from 
exogenous, and endogenous sources, and are administered to eliminate the 
infecting organisms at the site of infection (Stoutenbeek, 1989). However, 
this approach has enjoyed only limited success. This is because it does not 
primarily address the source of infection, and also because of major 
problems of drug resistance (McCoy, 1954; Hahn etal., 1978).
The major limitation of these approaches have provided the stimulus 
for other methods of infection prophylaxis that are focussed primarily on the 
major source of endogenous infection, that is AGNB and yeasts colonizing 
the digestive tract.
Two techniques have been described:
I. Total decontamination of the digestive tract (TDD).
II. Selective decontamination of the digestive tract (SDD).
1.4 Total Decontamination of the Digestive Tract:
TDD involves oral administration of broad spectrum antibiotics in an 
attempt to totally eliminate the aerobic, and the anaerobic flora of the 
digestive tract (gut sterilization) (Levineetal., 1973; Bodey and Rosenbaern, 
1975).To achieve TDD a variety of antibiotic regimens have been used 
(Table. 1). These regimens have proved surprisingly successful as a mean 
of sterilizing the intestinal tract and thus removing a major source of
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Table 1 Example of nonabsorbable antibiotic regimens used for total 
decontamination of the digestive tract.
Antibiotics Representative Reference
Gentamicin- Vancomycin -Nystatin Preisleret al., (1970)
Framycetin - Colistin - Nystatin Storring et al., (1977)
Neomycin - colistin - Nystatin Storring et al., (1977)
Vancomycin - Kanamycin - Nystatin King, (1980)
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endogenous infections (Levine et al., 1973; Bodey and Rodriguez, 1975; 
Dankert et al., 1978; Rodriguez et al., 1978; Pizzo, 1989). However, the 
application of TDD has been limited because of problems of drug 
resistance, poor patient compliance (King, 1980), and the need for a 
protective environment (sterilized food, and reverse isolation) (Kurrleetal., 
1881).
Drug resistance has proved particularly intractable. Following 
successful elimination of both aerobic, and anaerobic flora from the digestive 
tract, a substantial number of patients suffer overgrowth or colonization with 
organisms resistant to the TDD agents (particularly AGNB, yeasts and fungi) 
(Dankert et al., 1978). The digestive tract, in particular, may rapidly harbor a 
massive population of resistant strains. Endogenous transmission may then 
result in life threatening infection with drug resistant strains (Schimpff etal.,
1975).
These problems may be maintained after TDD is discontinued in the 
period required for recovery of the normal intestinal flora (Schimpff etal., 
1975; King, 1980).
1.5 The Concept of the Colonization Resistance and Selective 
Decontamination of the Digestive Tract:
The concept of colonization resistance (CR) was introduced by van 
der Waaij, and colleagues in 1971, in the Netherlands (van der Waaij et al., 
1971). They have defined CR as " The resistance which a potentially 
pathogenic microorganisms (PPM) encounters when it tries to colonize a 
landing site on the mucosal of one of the three tracts that have an open 
communication with the exterior" (van der Waaij, 1987). In the present 
context, the oropharynx and the gastrointestinal tract are the major sources 
of endogenous infections.
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There is considerable evidence to suggest that the indigenous 
anaerobic flora of the digestive tract plays a major role in the maintenance 
of CR at this site (van der Waaij etal., 1971; Welling etal., 1980). However, CR 
is a complex and multifactorial phenomenon which will be reviewed in 
subsequent section (1.11-1.12).
The method of SDD is based on the concept of CR (van der Waaij et 
al., 1971; van der Waaij and Berghuis deVries, 1974). Like TDD, SDD aims to 
achieve elimination of AGNB and yeasts from the digestive tract by the use 
of oral nonabsorbable antimicrobial agents. Unlike TDD, SDD uses 
antimicrobial agents with a selective action that has minimal effects on the 
overall numbers of anaerobic flora (Guiot and van Furth, 1977; van Saene, 
1987; de vries-Hospers et al., 1981). This, in turn, allows retention of CR 
which (together with exposure to high concentrations of antimicrobial 
agents), prevents colonization or overgrowth of the digestive tract with 
strains resistant to the decontaminating drugs (the major problem in TDD 
regimen) (van der Waaij et al., 1971; van Saene et al., 1983).
Clinical SDD regimens are designed to produce three main effects:
1) To eliminate or markedly reduce the AGNB, and yeasts present in the 
oropharynx, and the gastrointestinal tract.
2) To prevent acquisition and secondary colonization by AGNB and yeasts 
from hospital environments.
3) To prevent overgrowth or colonisation with strains resistant to the 
decontaminating agents.
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1.6 History of SDD:
The history of SDD can be traced back for more than 75 years. Nissle,
(1916) was the first to suggest that the resident microflora of the gut may 
prevent colonization with exogenous organisms. Thereafter many attempts 
have been made to solve the problem of endogenous infections from the 
digestive tract by oral administration of antimicrobial agents. In 1939, 
Garlock and Seley, were the first to describe the use of antimicrobial agents 
for intestinal flora suppression, when they recommended the oral use of 
sulphonamides for wound infection prophylaxis in colorectal surgery. 
Suppression of tracheal flora was first described by Lepper et al., (1954), 
where they used antibiotics following tracheotomy in poliomyelitis. Poth, 
(1960) was the first to suggest that augmentation of topical drugs with 
systemic agents in order to close gaps in the antibacterial spectra of the 
antibiotics used, and to prevent the development of resistance. As 
discussed, Van der Waaij and his group formally introduced the concept of 
CR in 1971 (Van der Waaij et al., 1971), and from this finding the concept of 
SDD evolved.
The first clinical use of SDD was described by Guiot and van 
Furth (1977) who applied the technique to leukaemia patients in 1977. They 
used a mixture of neomycin or kanamycin, polymyxin E or colistin, nalidixic 
acid, and amphotericin B or miconazole. This was administered orally as 
regimen for decontamination of the gut (Guiot and van Furth, 1977), and was 
called " partial antibiotic decontamination" . The result showed a rapid 
elimination of potentially pathogenic organisms from the intestinal tract. Only 
one out of nine patients developed endogenous infection, and exogenous 
infection was not recorded. The anaerobic flora of the gut seemed to remain 
normal during partial decontamination, and this was assumed to have 
maintained the CR (Guiot and van Furth, 1977).
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Since 1977, successful infection prophylaxis in leukopenia has been 
reported using a variety of SDD drugs. For example oral trimethoprim- 
sulphomethoxasole (TMP-SMZ) has been used alone, when the bacterial 
infection rate in leukopenic patients was reduced to between zero and 50 % 
of the infection rate in control patients (Hughes et al., 1977; Gurwith et al., 
1979; Gualtieri etal., 1983; Kauffman etal., 1983; Ribenetal., 1983; Esteyet 
al., 1984; Henry et al., 1984). Colonization with AGNB susceptible to TMP- 
SMZ was generally found to be reduced, but not eliminated. Dekker et al., 
(1981) reported a serious problem due to colonization, and infection with 
TMP-SMZ resistant AGNB, but this problem was solved by the addition of 
oral colistin to the TMP-SMZ regimen (Kauffman et al., 1983). Other studies 
have employed oral TMP-SMZ plus erythromycin (Pizzo et al., 1983), TMP- 
SMZ plus nystatin (Hughes et al., 1977; Mulder et al., 1979; Wade et al., 
1981), colistin plus neomycin (Storring et al., 1977; Rohatener and Lowes, 
1981), and colistin plus both neomycin and nalidixic acid (Guiot et al., 1983). 
Nalidixic acid with TMP-SMZ or polymyxin, and amphotericin B for the 
elimination of the yeasts have also been employed (de vries-Hospers et al., 
1981).
Clearly, successes have been recorded following the use of SDD in 
neutropaenic patienU. However, this has proved a large and very complex 
field, and opinion is still divided ofthe precise value ofSDD in this area.
Stoutenbeek et al.,(1983) described the use ofSDD regimen in acute 
trauma patients admitted to an unspecialized medico-surgical intensive 
care unit. This was the first application of SDD regimen to non-neutropenic 
patients, and the result was strikingly successful. The SDD regimen 
consisted of three drugs; polymyxin E, tobramycin , and amphotericin B 
(PTA). These drugs were administered to the stomach and more distal
35
gastrointestinal tract by means of a nasogastric tube, and were also applied 
directly to the oropharynx in a sticky "orabase" vehicle. This SDD regimen 
showed a striking reduction in unit-acquired infection from 81 % in control 
patients to 16 % for SDD patients. Respiratory tract infections, urinary tract 
infections, and septicemia were the major unit-acquired infections in both 
groups.
Stoutenbeek et al., supplemented the topical SDD drugs with 
systemic cefotaxime, during the first few days of treatment. This was 
employed for three reasons: to provide additional cover against AGNB 
during the first few days of treatment whilst SDD was established, to provide 
additional cover against organisms resistant to SDD agents (particularly 
gram positive respiratory pathogens) during intubation and other invasive 
procedures in the period following ITU admission, and to treat the 
appreciable proportion of patients already developing a lower respiratory 
tract infection at the time of admission (Alcock, 1990). The antimicrobial 
spectrum of cefotaxime was compatible with these aims whilst exerting a 
minimum effect on the anaerobic flora of the intestinal tract (and hence on 
CR).
This study made a considerable impact and since 1984 there have 
been numerous further studies in an ITU environment, mainly using the PTA 
regimen (with or without cefotaxime) (Table. 2). A summary of the acquired 
infections rates in 24 SDD trials is shown in Table 3. Results of these trials 
have been remarkably uniform . The incidence of oral and tracheal 
colonization with AGNB was reduced from 50% to 80% in control patients 
to 5 % to 15% in patients with SDD . Twenty of these SDD trials showed a 
statistically significant reduction in the rate of unit-acquired infection. Most 
of this benefit derived from a reduction in lower respiratory tract infections:
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Table 2 Prophylactic regimen based on a combination of topical and
systemic antibiotics*.
Topical Antim icrobials (PTA Regimen)
These are administered throughout the ICU stay
1) Oropharyngeal Cavity: A small volume of a 2 % mixture of 
polymyxin E, tobramycin and amphotericin B in paste with 
carboxy methyl
cellulose (Orabase) is applied to the buccal mucosa with a gloved 
finger 4 times a day.
2) Gastrointestinal Canal: 9 ml of suspension of polymyxin E 100 mg, 
tobramycin 80 mg and amphotericin B 500 mg is administered via the 
gastric tube 4 times a day.
Systemic Antimicrobials
Administered for the first 4 days of the ICU stay.
Cefotaxime 50 -100 mg / kg body weight/ day given intravenously.
* From van Saene etal., (1983).
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Table 3 Summary of % Acquired Infection in SDD trials 
1984-1991.
Reference ICU-Acquired-infection (%)
control SDD
1. Stoutenbeek, et al. (1984) 81 16*
2. Unertl, K., etal. (1987) 70 21*
3. Van Uffelen, R., et al. (1987) - 7
4. Ledingham, I., etal. (1988) 24 10*
5. Wiesner, R. H., etal. (1988) - 23
6. Kerver, A. J. H., et al. (1988) 81 39*
7.Sydow, M.,et al. (1988) 75 7*
8. Brun-Buisson, C., et al. (1989) 33 32
9. Konrad, F.,et al. (1989) 42 6*
10.Ulrich, C., etal. (1989) 44 6*
11. Thulig, B., et al. (1989) 46 10*
12.Guillaume, C., etal. (1989) 21 3*
13. Cockerill, F. R., etal. (1989) 62 24*
14. Thulig, B., etal. (1989abst.) 57 18*
15. Schardey, M., etal. (1989) 47 10*
16. McClelland, P., etal. (1989) 83 33*
17. Flaherty, J., etal. (1990) 27 12*
18. Aerdts, S. J. A., etal. (1990) 78/62& 6*
19. Tettero, G. W. M., et al. (1990) 55 21*
20. Wiesner, R. H., etal. (1990) - 28
21. Rodriguez-Ronald, e ta l (1990) 73 0*
22. Hartenauer, U., et al. (1991) 69.5 26* (IC U 1)
87.5 44.5* (ICU 2)
23. Pugin, J., etal. (1991) 78 16*
24. Blair, P., et al. (1991) 30.8 16.7*
* Statistically significant difference. 
&Two control groups.
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nosocomial pulmonary infection was reduced from a typical incidence of 60 
% in control patients to about 10 % in patients with SDD. In contrast, the 
effect of SDD on mortality remains unclear, and further studies employing 
much larger patients numbers are required.
The use ofSDD regimen in ICU remains highly contentious. Much of 
the criticism had centered on the inability to demonstrate a fall in ICU- 
associated mortality and on the possibility of major problems of drug 
resistance.
1.7 Emergence of Resistance During SDD:
SDD regimens apply mixtures of antimicrobial agents to vast 
microbial populations encompassing several hundred species. Intense 
selective pressure for resistance to the decontaminating agents is an 
inevitable consequence of this procedure. Against this factor are ranged the 
preservation of colonisation resistance and variable exposure to mixtures 
of potent bactericidal agents used at very high concentrations. In these 
circumstances the danger of major resistance problems has remained a 
justified concern.
However, significant problems have yet to be described. Patterns of 
drug resistance were closely monitored over a period of thirty months 
continuous SDD use by Stoutenbeek et al., (1987). No increase in 
resistance to PTA and cefotaxime was seen. This also has been the case in 
the study by Alcock etal., (1990) in Glasgow with five years of continuous 
use of the SDD regimen . It also has been reported that the emergence of 
AGNB was uncommon in patients during liver transplantation (Wiesner, 
1991). From other published trials of SDD, significant problems involving 
drug-resistant gram negative organisms have yet to be reported. Several 
studies have noted an increase of enterococci and coagulase negative
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staphylococci from the digestive tract of SDD patients (Poole etal., 1992) but 
this has not been associated with problems of infection.
In view of the rapidly extending clinically use and associated 
controversy in this area, it is pertinent to question the experimental bases for 
the concepts of colonization resistance, and selective decontamination of the 
digestive tract.
1.8 The Microbial Ecology of the Murine Intestinal Tract as A Model for 
that of Humans:
Mice have been extensively used to study human intestinal 
pathogens, the effects of antibiotics on intestinal flora (Meynell,1963; Meynell 
and Subbaian, 1963; Bohnhoff et al., 1964a, 1964b; van der Waaij, 1968; van 
der Waaij et al., 1971,1972; van der Waaij and Berghuis de vries, 1974), and 
the effect of enterotoxins produced by pathogenic microorganisms (Dubos 
and Schaedler, 1959, 1962; Schaedler et al., 1962). They have also been 
employed to study the influence of antimicrobial agents on colonization 
resistance (van der Waaij et al., 1971, 1972). The particular value of animal 
experimentation in this latter area is that it allows the administration of 
resistant microorganisms as a challenge strain, whereas a deliberate 
administration of resistant microorganisms to patients presents ethical 
difficulties and limits the possibilities for study of the fate of the challenge 
organisms.
There are many anatomical differences between the intestines of 
humans and mice e.g. the existence of a large caecum in mice. In addition, 
there are many differences in the intestinal microflora, which will be 
discussed in detail in the following section. However, in previous studies of 
colonization resistance, the intestinal microflora of mice and man appeared
to respond to antimicrobial agents in a similar fashion (van der Waaij, 1979; 
van der Waaij etal., 1982).
1.9 The Intestinal Microbial Flora:
In all mammals, including man and mice, the microbial colonisation of 
the new born infant is established immediately after birth. Infants are 
colonized by flora derived from the mother initially, and from other sources 
subsequently (Hurst, 1965). After only a few weeks in most cases, the 
representation of microbial species in these new born infants is remarkably 
similar to the adult pattern of colonization (Lee et al., 1971; Long and 
Swenson, 1977).
The intestine of adult man and animals harbours a complex mixed 
population of bacteria, and as the complexity of the flora increases, the 
ease with which new strains are able to become established is decreased 
(Sears, et al., 1956). The major microbial species represented in individual 
human or animal populations are usually characteristic, and difficult to 
change by means of diet or environment (Haenel, 1961).
There are two caveats associated with the study of the intestinal 
flora. Firstly, most of the studies especially those of the large intestine, have 
concerned themselves only with the microbial flora of the lumen, which may 
not reflect the microbial population of the mucosal surface. Secondly, in 
most studies, only a small proportion of the large number of species 
present ( as many as 400 in human colon) have been examined, a deficiency 
that particularly applies to the anaerobic flora.
1.9.1 The intestinal microbial flora in man:
This thesis is mainly concerned with large intestinal flora, but for the 
sake of completeness a brief description of the proximal intestinal tract flora 
is included.
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1.9.1.1 Aerobic normal flora:
The upper region of small intestine including the stomach, 
duodenum, jejunum, and upper ileum has a sparse microbial flora consisting 
predominantly of gram-positive facultative organisms. Streptococci, 
aerobic lactobacilli, diphtheroids, and fungi are major constituents, and their 
total concentration is generally less than 104 cells per ml of intestinal fluid 
(van der Reis, 1925; Gregan and Heyward, 1953; Goldstein et al., 1962; 
Shiner et al., 1963; Kaser et al., 1966; Donaldson et al., 1967; Cohen et al., 
1969; Drasar et al., 1969; Gorbach et al., 1969; and Hamilton et al., 1970). 
Many of these microorganisms are derived from the oral cavity, colonizing 
the stomach and upper intestine in a wave-like fashion following meals 
(Drasar et al., 1969). Some investigators reported a low concentration of 
conforms (less than 104 cell per ml) in the upper small intestine of normal 
subjects (Kaiser et al., 1966; Donaldson et al., 1967;and Hamilton et al., 
1970).
The lower small intestine, i.e. the distal and terminal ileum appears to 
contain a richer and more permanent flora than the upper. Although 
lactobacilli and streptococci are still predominant, Enterobacteriaceae 
occur more frequently, and the total count is in the region of 105 7 cells per ml 
(Nicholes and Glenn, 1940; Cregan and Hayworth, 1953; Bornside and 
Cohn, 1965; and Kelser et al., 1966). Facultative aerobic organisms such as 
enterococci and coliforms are also present in the large intestine (Plaut et al., 
1967; Nelson and Mata, 1970). Variation in concentration of faecal aerobic 
microorganisms is considerable: in 10% of healthy people, E.coli has been 
found at a level of 109 organisms/gram of faeces, in 37% at 106'8; and in 16% 
at 103 5 organisms / gram of faeces. Other gram-negative rods, such as 
Pseudomonas, Proteus, Klebsiella, Enterobacter, Serratia, and Cltrobacter
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species have been found in less than 5 % of healthy subjects, and the 
numbers were usually less than 105 organisms/gram of faeces (Koopman et 
al., 1978).
1.9.1.2 An aerobic normal flora:
The colon contains the largest total population of microorganisms of 
any region of the human body. Microbial counts, which exceed 1011 cells per 
gram of colonic contents in healthy individuals, are represented by more than 
400 species (Moore and Holdman, 1974). Anaerobes outnumber aerobes by 
a factor of 100:1 to 1000:1 (Finegold and George, 1989). Microorganisms 
commonly isolated from human faeces are listed in (Table.4).
Numerically, Bacteroides spp. are usually the predominant genus in 
the human intestine, present at approximately 1011 cells per gram dry content 
(Finegold et al., 1983). The two species most frequently isolated are 
Bacteroides vulgatus, and Bacteroides thetaiotaomicron. Among the gram- 
positive rods Bifidobacterium, Eubacterium, and Lactobacillus are usually 
predominant. Finegold et al., (1974,1977) reported that 100 % of specimens 
examined contained Clostridium species which were present at a mean 
count of 109 8 cells per gram of faeces. Peptostreptococcus, Ruminococcus, 
Veillonella, and Acidaminococcus are also commonly present (Holdman et 
al., 1976; Finegold etal., 1983).
1.9.2 The intestinal microbial flora in mice:
The available studies on mouse intestinal tract flora overwhelmingly 
concern the caecum and large intestine flora. In addition, no explicit 
distinction is usually made between large and small intestinal flora. Lee et 
al., (1971) reported that the anaerobic flora of the colon is qualitatively and 
quantitatively similar to the anaerobic caecal flora.
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Table 4 Colonic Microial Flora in Human'
Anaerobic bacteria Aerobic and facultative anaerobic bacteria
Gram-positive rods Enterobacteriaceae
Actinomyces Escherichia coli
Arachnia Citrobacter
Bifidobacterium Klebsiella
Clostridium Enterobacter
Eu bacterium Proteus
Lachnospira
Propionibacterium Pseudomonas
Gram-negative rods Lactobacillus
Bacteroides
Butyrivibrio Streptococcus
Desulfomonas Staphylococcus
Fusobacterium
Leptotrichia
Succinimonas
Succinivibrio
Wolinella
Gram-positive cocci
Coprococcus
Gaffkya
Peptococcus
Peptostreptococcus
Ruminococcus
Sarcina
Gram-negative cocci
Acidominococcus
Megasphaera
Veillonella
*From Finegold and George (1989) Drasar and Barrow (1985)
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1.9.2.1 Aerobic normal flora:
The aerobic normal flora in mice is similar to that in humans, 
consisting predominantly of E.coli, and enterococci, both in concentration of 
(approximately) 105organisms/ gram of faeces (Claseneretal., 1987). Lee 
et al., (1971) reported that enterococci and coliform bacilli were present in 
the caecum of new born mice before the strict anaerobes, and that their 
numbers decreased shortly after the time when the population of strict 
anaerobes reached their maximum. Brown and Balish, (1978) reported that 
Lactobacilli, Corynebacteria, and Enterococcus faecalis were the most 
numerous facultative and aerobic bacteria isolated from the stomach at a 
range of105-106 cells, whereas the facultative aerobicgram negative rods 
were present in lower numbers. However, E.coli was the major species of 
Enterobacteriaceae cultured from caeca of mice, and it reached a level of 
106 - 107 cells in the ilea of 8 out of 16 different strains of mice (Brown and 
Balish, 1978). The diversity of facultative gram negative fermenting rods 
increased in the caeca (as reflected by the occurrence of detectable levels of 
Proteus mirabilis, Enterobacter aerogenes, Klebsiella pneumoniae, and 
Acinetobacter species), whereas Ps. aeruginosa was isolated only from 
small numbers of mice (Brown and Balish, 1978).
1.9.2.2 Anaerobic normal flora:
The gastrointestinal tract of normal healthy mice contains a total 
population of 1010 -1011 anaerobic organisms per gram of intestinal contents 
(Moore etal., 1963; Savage etal., 1971) that consists of a large diversity of 
species. Direct microscopic examination of the intestinal contents showed 
that the predominant morphotypes of the anaerobic population were gram 
negative rods with pointed ends, although the gram positive rods, and cocci 
were also present in smaller numbers (Gordon and Dubos, 1970; Lee et al.,
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1971; Harris et al., 1976). These organisms, and also gram negative non- 
sporulating rods with rounded ends, were found to be obligate anaerobes. 
They were assigned to the genera Bacteroides and Fusobacterium 
respectively (Lee etal., 1968; Gordon and Dubos, 1970; Harris et al., 1976;, 
Gordon and Dubos, 1970; Lee etal., 1971; Savage etal., 1971; Harris etal.,
1976). These were present at a level of 1010 -1011 organisms / gram of caecal 
content. Eubacterium species were also present at a level of 1010 - 1011 
organisms / gram of caecal content (Gordon and Dubos, 1970), and this 
species was also isolated from a 1010 - 1011 dilution of the colon content 
(Harris et al., 1972). Lactobacilli (Moore et al., 1963; Dubos et al., 1965; 
Holdman and moore, 1972), Propionibacterium, and Peptostreptococcus 
(Harris et al., 1976) were present, but in lower numbers; for example Moore 
and Holdman, (1963) reported a concentration of 106- 108 Lactobacilli per 
gram of small intestine contents, and Harris et al., (1976) reported that 10“ 
Lactobacilli were present per gram of colon contents. Clostridium species 
were found at 107 and 108 dilutions of the mouse caecal contents and of 
faeces respectively (Dubos et al., 1965; Gordon and Dubos, 1970). Brown 
and Balish, (1978) observed that the greatest diversity of species of one 
genus was seen in the Lactobacilli (19 species), and Bacteroides (18 
species). This finding, together with a comparison of the colon flora of 
mice and humans, is summarized in Table. 5.
1.10 Mice as Models of Decontamination of the Digestive Tract in 
Humans:
In humans many different antibiotics and combination of antibiotics 
have been used for reducing the microbial flora of the intestines prior to 
operations (Cohn and Longacre, 1956; 1957; Klastersky et al., 1975; 
Stoutenbeek et al., 1986), and as a treatment of certain gastrointestinal
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Table 5 Organisms in order of prevalence in human and mice 
colon*.
Human Mice
Anaerobic bacteria
Bacteroides Bacteroides
Bifidobacterium Fusobacterium
Eubacterium Eubacterium
Clostridium Propionibacterium
Peptostreptococcus Peptostreptococcus
Ruminococcus Clostridium
Veillonella
Acidominicoccus
Aerobic and facultative anaerobic bacteria
Lactobacillus E.coli
Streptococcus Enterococcus
Staphylococcus Lactobacillus
diphtheroids Corynebacterium
Enterococcus Proteus
E.coli Klebsiella
Proteus Acinetobacter
Pseudomonas Pseudomonas
Enterobacter
Serratia
Citrobacter
* From Lee etal., (1971); Harris etal., (1976); Brown and Balish (1978); Drasar 
and Barrow (1985) and Finegold and George (1989).
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diseases such as enterocolitis (Stralford and Dixon, 1964). In most cases a 
marked reduction of the faecal flora was obtained.
These clinical applications have been successfully modelled in 
C57BL/Rij, CBA/Rij, C3H, RFO, and ND22 mice. A combination of bacitracin 
with either kanamycin, streptomycin, or neomycin was administered in the 
drinking water at 4 g I1 (van der Waaij and Sturm, 1968). Decontamination 
was accomplished in 4 days in 94 % of groups of 30 - 100 mice, and 
maintained for as long as 12 weeks, without overt signs of intoxication due to 
antibiotics. Another study modelled the clinical use of TDD (kanamycin and 
chloramphenicol) in neutropenia using CBA/Rij, C57BL/Rij, and ND2 mice 
(van der Waaij, 1968). Effective TDD was achieved and after discontinuation 
of TDD treatment, the normal flora recovered in two weeks. This study also 
found that TDD mice could easily be colonized with gram negative rods 
before recovery of the normal flora, whereas after recovery of the normal 
flora, mice appeared to be more resistant to colonisation with gram negative 
rods.
Several studies have shown that following treatment with 
antimicrobial agents the phenomenon of overgrowth by resistant bacteria 
occurred in mouse gut as well as in humans (Bohnhoff et al.,1954; Freter, 
1955; 1956; Clark, 1971). Most authors who reported gastrointestinal tract 
decontamination in mice or humans, mentioned cases in which colonization 
with yeasts occurred; Shidlovsky et al. (1955) tried to solve this problem by 
adding Kaprylex (caprylic acid combined with a polyamine) to the 
antibiotics, whereas others (Spaulding et al., 1955; Meyer, 1962) have 
employed the fungicidal drugs nustatin or Amphotericin B with success.
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1.11 The Experimental Basis of the Concept of Colonization Resistance 
and Selective Decontamination of the Digestive Tract:
The experimental basis and the theory behind the concept of 
colonization resistance is largely dependent on a series of studies which 
were performed between 1971 -1974 by van der Waaij and colleagues in 
the Netherlands (van der Waaij et al., 1971; Wensinck et al., 1971; van der 
Waaij et al., 1972; van derWaaij and Berghuis de Vries, 1974).
Perhaps the most important study involved total decontamination of 
the digestive tract of Swiss ND2 mice using a combination of broad- 
spectrum nonabsorbable antibiotics, namely streptomycin and neomycin, 
given ad libitum in drinking water for a period of two weeks (van der Waaij et 
al., 1971). The study was divided into 4 phases:
Phase I :The period before antibiotic treatment (control mice).
Phase II : The actual treatment period.
Phase III : The period in which organisms surviving the treatment 
repopulated the intestinal tract.
Phase IV : When repopulation was completed. Two weeks after 
discontinuation of antibiotic treatment.
Treated mice became free of detectable Enterobacteriaceae, 
enterococci, staphylococci and of yeasts and other fungi during phase II. 
Groups of 20 mice were challenged or deliberately contaminated with 
streptomycin-neomycin resistant strains of E.coli, Kl. pneumoniae, or Ps. 
aeruginosa using different doses at different phases of antibiotic treatment. 
The result showed that the number of phase I (control) and phase IV 
(recovery) mice excreting the three challenge strains gradually decreased, 
and that this decrease was more rapid with lower doses of the challenge 
organisms. In contrast, persistent colonization with the three challenge
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organisms took place in all phase Hand phase III mice. From these results 
they concluded that there was a process that was associated with the 
elimination of orally introduced organisms , and this mechanism was 
termed "ColonizationResistance".
Van der Waaij et al., (1971) suggested that colonization resistance 
could be determined semi-quantitatively by expressing colonization 
resistance as the log of the oral dose of challenge organisms resulting in 
colonization of 50 % of the animals for at least two weeks. The value of 
colonization resistance in control mice was then found to be slightly 
different for the three challenge strains tested: the CR of phase I mice to 
E.coli was 7, whereas the CR to Pseudomonas aeruginosa or Klebsiella 
pneumoniae was > 9. The statistical significance for this observation was not 
stated by the author, and these results may be within experimental error. 
After the onset of oral administration of antibiotics colonization resistance 
decreased, and the value remained low (less than 2) for the three 
organisms during the treatment period. There was a slow recovery of CR 
during phase III, which returned to normal levels at phase IV (recovery).
1.12 Mechanism Of Colonization Resistance:
1.12.1 Implication of the anaerobic bacteria in CR:
Wensincket. al. (1971) studied the caecal flora of groups of 5 Swiss 
ND2 germ-free mice contaminated with the faecal flora of phase IV 
(recovery) ND2 mice from the TDD experiments of van der Waaij et. 
al.,(1971). Five species of anaerobes were detected in this simplified 
population. Anaerobic lactobacilli and Bacteroides, the predominant 
anaerobes of conventional mice (see section 1.9.2), were absent; the major 
constituents were tapered rods belonging to the genus Clostridium 
(Wensinck etal., 1971). Germ-free mice colonized withtheflora of phase IV
offspring were termed colonization resistance factor mice (CRF-mice) (van 
der Waaij et al., 1971) . These reconstituted germ-free mice and their 
offspring were found to be highly resistant to colonisation with E. cofi as a 
challenge organism (higher than untreated normal mice). This study neither 
determined which of the CRF organisms was most associated withCR, nor 
a mechanism by which CR operated. In addition, the intestinal microbial 
flora was not characterized before treatment with TDD antibiotics (van der 
Waaij et al., 1971). It was therefore not possible to know whether the CRF 
flora was represented in the normal flora of mice. It was nevertheless 
suggested, that colonization resistance was due to anaerobic organisms 
which survived the TDD antibiotics, and subsequently repopulated the 
intestinal tract. Van der Waaij also reported that results from preliminary 
experiments with germ-free mice contaminated with various combinations 
of these five species strongly suggested that colonization resistance was 
due to the presence of a large gram-labile tapered Clostridium (van der 
Waaij etal., 1971).
Koopman et al., (1981) fundamentally disagreed with the conclusion 
of van der Waaij etal., (1971), namely that CR can be restored with asimple 
anaerobic microflora of only 5 strains. They attempted to normalize germ- 
free mice, and to obtain mice with a standardized gastrointestinal microbial 
flora. Five groups of germ -freeCpb:SE (Swiss) mice were colonized with 
different anaerobic cultures obtained from the faeces of CRF-mice, and of 
specific pathogen free-mice (SPF-mice), containing respectively 36 strains, 
55 strains, 110 strains, or the complete microbial flora. Mice were then 
challenged with 107 E.coli resistant to streptomycin. Colonization resistance 
and other parameters were investigated to assess the normalization of 
germ-free mice. The results showed that the colonization resistance
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against oral challenge with E.coli (107 cfu) was relatively low in germ-free 
mice, and relatively high in SPF-mice. Despite the numbers of strains with 
which the mice were colonized, the CR was found to be less than that of the 
SPF-mice, though it was greater than that of germ-free mice. These results 
suggested either that to normalize germ-free mice a very complex 
gastrointestinal microflora is needed, or that the strains associated withCR 
in normal mice were not represented in the flora with which the germ-free 
mice were colonized in this experiment (Koopman et al., 1981). In addition, 
the intestinal architecture and immunocompetence of germ-free mice differs 
from that of normal mice, and this may have had effects on the CR 
(Koopman etal., 1981).
Studies conducted by Syed et al., (1970), and Freter and Abrams, 
(1972) were able to normalize the CR of germ-free mice only with more than 
100 bacterial strains, using the relative caecal weight (RCW) and other 
parameters. This supports the suggestion of Koopman etal., (1981) that 
normalization can only be reached with a complex microbial flora.
Other attempts have been made in mice, by the administration of 
cultures of anaerobic bacteria to germ-free mice, to analyze which species of 
the anaerobic flora are responsible for resistance to colonization with 
aerobic microorganisms. Administration of Bacteroides strains isolated 
from normal mice led to a massive colonization in groups of 20 germ-free 
mice, but did not produce recovery of resistance to colonization to aerobes. 
However, this did occur after administration of fresh faeces of normal NCS 
mice (Schaedler et al., 1965R-8-96). Apparently successful attempts were 
made to restore CR to germ-free mice using a large fusiform bacterial 
species (Wensinck et al., 1971; Hazenberg et al., 1981); however, in spite of
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further study, the identity of this species remained vague (Hazenberg etal., 
1976; 1977) and later it appeared that dozens of different species with this 
morphology live in the intestine of mice (Koopman and Kennis, 1983; 
Koopman et al., 1983). The above studies appear to indicate that the more 
species of anaerobes that were discovered, the more species appeared to 
be necessary to restore the colonization resistance of the intestine of the 
germfreemice (Koopman and kinnes, 1980; Welling etal., 1980). In general, it 
appears that complete normalization with a relatively simple microflora is 
probably not feasible.
There are further studies in mice and in humans that suggest that 
the anaerobes are part of first line defence in the gut, and a major factor in 
colonization resistance. Van der Waaij et al.,(1972), described the influence 
of systemic antibiotic treatment on colonization resistance after oral 
challenge of mice. Groups of 30 ND2 mice were treated with 5 mg of 
streptomycin given by i.p. injection twice a day, or with 10 mg of ampicillin 
given by i.p. injection; control mice were injected with saline. On the third day 
of treatment, mice were challenged with 108 or 101° cells of E.coli, or 
enterococci. A strong negative influence of high dose of systemic antibiotics 
on colonization resistance was found. The challenge strain persisted much 
longer and in a much higher concentration in the caecum of systemically 
treated mice than in control mice. Also, translocation of the challenge strain 
into the mesenteric lymph nodes and the spleen was found much more 
frequently in the antibiotic treated group. From these results they suggested 
that colonization resistance is due to the anaerobic flora that live in close 
contact with the mucosa, although the status of mucosal anaerobes was not 
investigated in this study. In a further study by van der Waaij andBerghuis de 
Vries, (1974) mice were given 10 mg m l1 nalidixic acid ( NA) in drinking water
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for 3 weeks, and monkeys were given 500 mg NA administered orally twice a 
day in 5 ml of water. The enterobacteria were successfully eliminated from 
the faecal flora of both mice and monkeys within 9 days of treatment. As the 
concentration of enterococci and Candida albicans remained unchanged 
during treatment, it was suggested that the colonization resistance was not 
affected. This study therefore used non-overgrowth of indigenous 
organisms rather than colonization by challenge strains as a criterion of CR. 
Again, the anaerobic flora was not studied directly, but assumed to be 
unaffected by the drugs used. As the nalidixic acid eliminated the 
enterobacteriaceae, the anaerobes which were assumed to remain were 
assumed to be responsible for the CR.
Vollaard et al., (1990) performed a study in humans , and they 
reported that it was not possible to colonize the gut with a Klebsiella 
pneumoniae challenge strain after eliminating the E.coli from the gut by a 
dose of 20 mg of pefloxacin. However, in the same study when mice were 
treated with clindamycin which eliminated the anaerobic flora from the gut, 
Klebsiella pneumoniae easily colonized the gut. The authors therefore 
suggested that the anaerobic flora are responsible for colonization 
resistance. However, clindamycin also does not affect only the anaerobic 
flora. Wells et al., (1988), colonized germ-free Balb/c mice with E.coli and 
other aerobic and anaerobic organisms obtained from the caecal content of 
mice, to study and to clarify the role of the intestinal anaerobic bacteria in 
CR. They also concluded that the anaerobic bacteria play a major role in 
colonisation resistance and also in controlling translocation of facultatiye 
anaerobic bacteria.
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1.12.2 Suggested mechanisms by which anaerobes exert their 
effect on CR:
Strictly anaerobic bacteria are thought to exert this activity directly by 
producing toxic metabolites such as the volatile fatty acid (VFA) (Bohnhoff 
and Miller, 1962; Dubos and Schaedler, 1962; Meynell, 1963; Lee and 
Gemmell, 1972) which may inhibit the multiplication of non-indigenous 
organisms. It has been shown previously that the normal microbial flora 
destroys ingested yeasts (Montgomery et al., 1931) possibly because of the 
toxic effect of VFA on fungi (Bergien, 1940). This substance also prevents 
the conversion of yeasts forms into invasive mycelial forms (Barlish and 
Phillips, 1966; Phillips and Barlish, 1966). Similarly it has also been shown 
that VFA produced by the anaerobic colonic flora inhibits Pseudomonas 
aeruginosa in vitro (Buck and Cooke, 1969). However, VFA can not explain 
fully the requirement of a complex microflora for the restoration ofCR, and 
the actual mechanisms by which anaerobes exert CR are unknown.
1.12.3 Implication of factors other than anaerobes inCR:
Although many studies suggested that the anaerobes are part of first 
line defence in the gut, and play an important part in colonization resistance 
and in prevention of overgrowth by AGNB (as described above) , other 
studies have indicated that the facultative anaerobic bacteria (Freter and 
Abrams, 1972; Koopman et al., 1981; Hentges et al., 1985) and aerobic 
bacteria (Freter and Abrams, 1972; Ducluzeau et al., 1977; Goren et al., 
1984) are also involved in the protection of animals against overgrowth with 
potentially pathogenic bacteria, and that they therefore contribute toward 
the colonization resistance. Hentges et al., (1985) studied the effect of
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selective antibiotic modulation on colonization resistance to orally 
administered drug resistant strains of Ps. aeruginosa in Swiss mice. These 
investigators noted that a larger oral dose of the challenge strain was 
required to colonize mice treated with metronidazole , ampicillin, or 
clindamycin (affecting both aerobes and anaerobes), than those treated with 
kanamycin or streptomycin (affecting aerobes only), suggesting that both 
aerobic and anaerobic organisms were involved with colonization 
resistance.
There are other factors, including competition between the intestinal 
normal flora and non-indigenous challenge organisms for limited nutrients 
or for adherence to sites of attachment on the intestinal mucosal cells and 
establishment by the normal flora of environmental conditions that adversely 
affect the non-indigenous organisms (Meynell, 1963; Bohnhoff etal., 1964; 
Lee and Gemmel, 1972; Mayer et al., 1972; Levison, 1973; Byrne and 
Dankert, 1979; Snoeyenbos, 1979; Bibel et al., 1983; Freter et al., 1983a; 
1983b; Hentges, 1983; Nordetal., 1984; Louie etal., 1985).
Host factors probably also contribute to the colonization resistance of 
the digestive tract. These include four major mechanisms: saliva and mucin 
production; saliva swallowing and peristaltic activity of the intestines; the 
excretion of immunoglobulin A with saliva and mucin; and the 
desquamation of mucosal cells (van der Waaij et al., 1982). These host 
activities limit the adherence of potentially pathogenic bacteria with the 
resultthatthe chance of their colonizing part of the digestive tract is reduced. 
Anaerobic normal flora may also indirectly exert an influence on these host 
factors by stimulating the secretion of mucin, cell desquamation, muscular 
tonus of the intestine and peristaltic activity (Gordon and Pesti, 1971).
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1.13 Evaluation of Colonization Resistance:
The concentration of resistant challenge organisms in the faeces 
following experimental oral challenge as described by van der Waaij et al., 
(1971) is one of the most direct indicators of colonization resistance and 
allows the generation of quantitative results. In addition, the following 
variables have used to assess CR: the relative weight of the caecum 
(Koopman and Janssen, 1975; Koopman et al., 1977; Emmelot and van der 
Waaij, 1980; Rugi, 1985) and the concentration of 8-aspartylglycine (8- 
aspgly) in the faeces (Welling, 1979; Emmelot and van der Waaij, 1980; 
Manson et al., 1981; van der Waaij et al., 1982).
The calculation of the relative weight of the caecum (RCW) (weight 
of caecum / weight of body) has been used because it has been shown that 
the RCW increases when the colonization resistance is impaired (Koopman 
and Janssen, 1975; Koopman et al., 1977; Ruijs and van der Waaij, 1985). 
This increase in the RCW is thought to be because mucus, normally digested 
by anaerobes accumulates in the caecum. This value appeared to be a good 
indicator for the colonization resistance in mice; Koopman et al., (1977) 
found a linear inverse correlation between the colonization resistance and 
the relative caecal weight. Other studies have also reported that the mean 
weight of the caecum in mice with a disturbed intestinal microbial flora and 
decreased colonization resistance due to antibiotic treatment is larger than 
that of control conventional mice; Thijmand van der Waaij, (1979) indicated 
that the colonization resistance was strongly decreased during systemic 
treatment with ampicillin or epicillin and there was an associated increase 
in the mean caecal weight of these mice compared to control conventional 
mice. Similar results have recorded by others (van der Waaij et al., 1982;
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Ruijs and van der Waaij, 1985).
Beta-aspartylglycine is formed in the course of digestion of collagen 
and other proteins from preexistent anhydro-aspartyl-glycyl bonds (Pisano 
et al., 1966) by preferential ring opening on the alpha-carbonyl bond and due 
to the metabolic inertness of the B-aspartyl bond. It is a dipeptide of 
molecular weight 190.2 (Figure.1). It is continuously secreted into the 
intestine, and is present in the faeces and caecum of germ-free or totally 
decontaminated intestines of mice and humans (Welling and Groen, 1978; 
Welling, 1979) and in normal urine (Buchanan etal., 1962a; 1962b; Tanaka and 
Nakajima, 1979). In one study by Welling and Goren (1978), the 
concentration of 6-aspgly was observed to be 200 times greater in the 
caecum content of germ-free and totally decontaminated mice than in the 
caecum of normal mice. This difference was attributed to breakdown of 6- 
aspgly by the anaerobic normal flora (Pisano et al., 1966). Van der Waaij et 
al., (1982) found that the total count of anaerobic bacteria (tapered rods and 
fusiform bacteria) was approximately inversely proportional to the 6-aspgly 
concentration in the faeces. These observations also appear to be valid for 
man and other animal species (Welling et al., 1980).
As a consequence of these studies, 6-aspgly has been used as an 
indicator of the effect of different antibiotics on anaerobic flora of the gut and 
hence on colonization resistance (Welling, 1979; Emmelot and van der Waaij, 
1980; Manson et al., 1981; van der Waaij et al., 1982). Cephradine led to the 
presence of 6-aspgly in the faeces of mice when given at doses of 280 mg / 
kg, and in monkeys when given when given at a dose of 90 mg / kg (Manson 
et al.,1981) and in humans when given a dose of 6 g / day (van Saene and 
Driessen, 1979).
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However, 8-aspgly was also found to have increased even with low 
doses during treatment with gentamicin or amikacin in the faeces of Swiss 
mice (van der Waaij et al., 1982). This is not consistent with 8-aspgly being 
inversely proportional to the anaerobes as these drugs have no direct 
activity against anaerobic populations. As aminoglycosides are frequently 
used in gut decontamination regimens, care is obviously required in the 
interpretation of 8-aspgly data obtained in this context.
In general there would appear to be no convincing substitute for 
direct challenge studies in the assessment of CR and other techniques 
should probably be regarded as a source of supporting data only.
1.14 Influence of Antimicrobial Agents on Colonization Resistance:
The differential effect of antimicrobial agents on CR is central to the 
concept of selective decontamination of the digestive tract. In the past twenty 
years this phenomenon has been studied in animal models either as a 
probe to alter the resident normal flora of the gut (Meynell, 1969; Meynell 
and Subaian, 1963; Bohnhoff etal., 1964*; 1964b; van der Waaij 1968; van der 
Waaij et al., 1971; 1972; van der Waaij and Berghuis de Vries, 1974) or to 
identify antimicrobial agents that would preserve the colonization 
resistance (Thijm and van der Waaij, 1979; van derWaaij etal., 1982).
From these studies it has been concluded that antibiotic drugs can 
be grouped in three major classes in term of their influence on the CR of the 
digestive tract (van der Waaij etal., 1979; Wiergersmaetal., 1982).
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1.14.1 Antimicrobial agents which do not affect the CR even when 
administered in very high oral doses.
In tests with tobramycin, amikicin, gentamicin, paromomycin and 
streptomycin, only tobramycin used in high doses (maximum dose 2.9 mg 
ml"1) did not affect CR in mice (van der Waaij etal., 1982; Hentges etal., 1985). 
The CR was measured using 3 parameters; the concentration of 6-aspgly, 
the relative caecal weight and the mean faecal concentration following oral 
challenge with E.coli, or Kl. pneumoniae (van der Waaij et al., 1982).
Polymyxin B, a narrow-spectrum antibiotic did not influence the CR 
even after relatively high oral doses o f9 .7m gday1 (Emmelot and van der 
Waaij , et al., 1980). This was determined using the concentration of the 
challenge organisms in the faeces, the RCW, and 6-aspgly concentration in 
the faeces (Emmelot and van der Waaij, etal., 1980).
Of the cephalosporins tested, cephradine in a dose of 3.4 mg 
mouse1 had no effect on CR (Thijm and van der Waaij, 1979). These 
experiments used the RCW and the concentration of the challenge 
organisms in the faeces as an indicator of CR. Other cephalosporins such as 
cephalexin and cefaclor both in doses of 4.6 mg mouse1 (Wiegersma et al., 
1982) acted in the same way as cephradine. The CR was not affected as 
estimated using 3 parameters; the relative caecal weight, the concentration of 
the challenge organisms in the faeces and the concentration of the 
indigenous Enterococci faecalis in the faeces Wiegresma, 1982). The fact 
that these antibiotics does not affect CR may be due to the complete 
absorption of these drugs in the small intestine, even during high dose oral 
treatment.
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Three ofthequinoloneswere found not to affect CR at high doses. In 
study by van der Waaij et al., (1974) using mice and monkeys, CR was not 
affected by relatively high (but not toxic) doses of nalidixic acid. Mice were 
treated with 1 g kg '1 body weight, whereas monkeys were treated with 0.3- 
0.5 g kg'1 body weight. The lack of overgrowth of indigenous Enterococcus 
faecalis and yeasts was used as an indicator of CR. The same result was 
seen in a study byWiegersma etal., (1982). They reported that CR was not 
affected when mice were treated with daily doses of 14 mg mouse'1 of 
nalidixic acid, or 15.2 mg mouse'1 of cinoxacin. CR was estimated as above. 
Rosoxacin did not affect theCR even during treatment with a daily dose of 6 
mg mouse'1 (Ruijs and van der Waaij, 1985). The relative caecal weight, the 
concentration of 8-aspgly in the faeces and the concentration of the 
indigenous Enterococcus faecalis in the faeces were used as a parameter for 
CR (Ruijs and van der Waaij, 1985).
Wiegersma etal., (1982) studied the effect of different antibiotics on 
CR measured by the relative caecal weight, the concentration of the 
challenge strain in the faeces and the concentration of the indigenous 
Enterococcus faecalis in the faeces. Antibiotics such as co-trimoxazole 
(1.1 trimethoprim + 5.8 mg sulphamethoxazole per mouse), pivmecillinam 
(> 2.5 mg per mouse) or doxycycline( 1.2 mg per mouse) were found not to 
affect the CR (Wiegersmaetal., 1982).
Amphotericin B or nystatin have been used to eliminate yeasts from 
the intestine. These agents have had no effect on CR, but it has been 
suggested that amphotericin B was superior to nystatin (van der W aaij, 
1979).
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1.14.2 Antimicrobial agents that do not affect CR during treatment 
with low doses, but produced a decrease in CR following high doses:
Of the aminoglycosides, neomycin decreased CR in mice when 
given in doses higher than 4 mgrnl1 (Emmelotand van der Waaij, 1980). This 
decrease in CR was determined using the concentration of the challenge 
organisms in the faeces, the relative caecal weight and B-aspgly 
concentration in the faeces (Emmelot and van der Waaij, 1980). Similar 
results were obtained with amoxycillin at doses > 1.6 mg mouse1: the 
relative caecal weight was increased and the concentration of the challenge 
organism was higher and persisted longer than in control mice (Wiegersma 
et al., 1982). A similar effect was seen with norfloxacin at a dose >3 mg 
mouse'1 (Ruijs and van der Waaij, 1985).
1.14.3 Antimicrobial agents which decrease the CR even when 
given at low doses:
In tests with aminoglycosides kanamycin ( at a dose of 1 mg ml'1) or 
streptomycin (at a dose of 5 mg ml'1) severely decreased the CR in mice, as 
estimated by the increase of susceptibility of mice to colonization with a Ps. 
aeruginosa challenge strain (Hentges etal., 1985).
Most penicillins severely affected CR: penicillin V (at a dose of 0.5 mg 
mouse'1), cloxacillin (at 0.6 mg mouse1), phenethicillin (at 0.7 mg mouse'1) 
(Wiegersma et al., 1982), ampicillin (at 0.5 mg mouse1), epicillin ( at 0.6 mg 
mouse'1) (Thijm and van der Waaij, 1979; Hentges et al., 1982), azlocillin and 
mezlocillin (both at > 0.86 mg mouse1) (van der Waaij et al., 1982). In these 
studies, the concentration of the challenge organisms in the faeces, the 
relative caecal weight and the concentration of indigenous Enterococcus
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faecalis were used to measure CR. The decrease in CR seen in these 
experiments was frequently associated with bacterial overgrowth in the 
digestive tract by resistant strains (Laura and Kaminski, 1962; Pollack etal., 
1972).
In tests with cefuroxime, cephradine, cephalexin, cefaclor and 
moxalactam, only cefuroxime and moxalactam ( both at doses of > 0.86 mg 
mouse1) were active against the anaerobic flora of the intestine, and 
decreased the CR in mice (van der Waaij etal., 1982).
Other drugs such as clindamycin, which has high activity against 
anaerobic bacteria (at a dose of 1 mg m l1,) severely decreased the CR. This 
was estimated by the increase in susceptibility of mice to colonization with 
a Ps. aeruginosa challenge strain (Hentges etal., 1985).
In summary the effects of the drugs used in the present study are as 
follows:
1) TDD antibiotics: Neomycin in low doses did not affect CR, whereas when 
given in higher doses of (> 4 mg m l1) the CR was reduced. Similar results 
were seen with streptomycin which decreased CR only when given at doses 
of > 5 mg ml'1 to mice. When combined these two drugs were associated 
with total decontamination of the digestive tracts and severe impairment of 
CR in mice (van der Waaij et al., 1971).
2) SDD antibiotics: Tobramycin (at a maximum tested dose of 2.9 mg ml'1) 
did not effect CR in mice. Similar results were seen with polymyxin at a 
maximum dose of 9.7 mg day1. A combination of the two drugs with the 
addition of amphotericin B was widely employed in clinical practice as a 
regimen for selective decontamination of the digestive tract (Stoutenbeek et 
al., 1984) with results that strongly suggest no significant impairment of CR.
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Unfortunately, there have been no direct studies on the effect of this SDD 
regimen on CR as measured by oral challenge of experimental animals.
In clinical trials, cefotaxime was added to the SDD drugs in the first a 
few days to provide additional cover against AGNB during treatment whilst 
SDD was becoming established and to provide cover against gram-positive 
bacteria resistant to SDD agents (Alcock, 1990). There have been no 
previous studies on the effect of cefotaxime alone on CR. However, 
cefotaxime was chosen because when used alone it is thought to have only 
minimal effects on the TVC of anaerobic flora and is thus unlikely to impair 
intestinal CR (Todd and Brogden, 1990).
AIMS OF THESIS
Aims of Thesis
The previous review has described the long standing use of the 
techniques of total decontamination and of selective decontamination of the 
digestive tract in certain groups of patients. In particular, the last ten years has 
witnessed the extension of selective decontamination to medico-surgical 
intensive care patients, a procedure that remains highly contentious.
The rationale of selective decontamination depends crucially on the 
concept of colonization resistance. However, the mechanisms underlying this 
phenomenon are both complex and controversial. Further, the experimental 
work underpinning the clinical use of SDD depends to a great extent upon a 
restricted series of studies involving the total decontamination of mice carried 
out by van der Waaij and co-workers between 1971 and 1974.
Againstthis background thethesis has two main aims:-
1) To repeat the original total decontamination studies of van der Waaij and 
colleagues in order to verify or modify their conclusions.
2) To use the same mouse model to study the SDD regimen most commonly 
used in clinical ICU practice - an orally administered mixture of polymyxin E, 
tobramycin and amphotericin B (PTA) supplemented with systemic cefotaxime.
The techniques employed centred upon direct oral challenge of mice 
with bacterial species of defined characteristics, together with detailed 
microbiological monitoring of the aerobic and anaerobic flora of the gut.
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Chapter Two
MATERIALS AND METHODS
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2. Materials And Methods:
2.1 Animals:
Conventional inbred female Balb/c /OLa mice (Harlen Olac, Shows 
Farm, Bicester, England), varying in age between 8 -16 weeks, and weighing 
between 18-24 gram were used.
2.1.1 Wild mice:
Wild mice were obtained by placing a number of small mammal steel 
traps overnight in a field at the University of Glasgow biology field station at 
Rowardennan. Three wild mice were captured, moved to the laboratory and 
killed using cervical dislocation on the same day. Faecal pellets , and the gut 
content after dissecting the mice, were assayed for aerobic flora, anaerobic 
flora, and 6-aspartylglycine.
2.1.2 Housing conditions:
Mice were housed individually in autoclaved polypropylene cages (size 
M 1:33 x 15 x 13 cm), covered with stainless steel tops, with autoclaved wood 
shavings as bedding. For housing groups of 8-16 mice sizeMB1(45x 28 x 13 
cm) autoclaved cages were used. The experiments were carried out in a normal 
animal room. Control, treatment, and post-treatment mice were kept in 
separate rooms. Cages, and wood shavings were changed daily.
2.1.3 Diet:
Food and water were given ad libitum . Control and post-treatment 
mice were given sterile water acidified after autoclaving to pH 3 with HCI. 
During antibiotic treatment, mice were given unacidified sterile water. Food 
consisted of sterile irradiated pellets (G/P grade diet irradiated, Biosure 
Cambridgeshire, England).
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2.2 Antibiotic Treatment Of Mice:
Antibiotics were used singly and in combination1 to study the effect on 
CRofTDD and of SDD.
2.2.1 Antibiotics used for TDD of mice:
For total elimination of the normal flora of the gut, a combination of 
streptomycin sulphate (Sm) (Sigma chemical company Ltd., Dorset, England). 
and neomycin sulphate (Nm) (Sigma), at 5 mg ml'1 of each antibiotic, was given 
in drinking water, to which pimaricin (Sigma) 0.1 mg. ml'1 was added as an 
antifungal agent (TDD regimen). The TDD regimen was continued ad libitum 
for a period of 2 weeks. During treatment the drinking water bottle was 
wrapped with aluminium foil to protect itfrom the light, since pimaricin is light- 
sensitive. The antibiotics and the drinking water were changed every 5 days, as 
neomycin isunstaible at room temperature (see section 2.6.1).
For comparative purposes, Sm (10 mg) + Nm (10 mg) in 0.2 ml water 
were administered to mice by gavage in one experiment. In some TDD 
experiments 3 mg. ml'1 of bacitracin (Sigma) was added to the TDD regimen to 
eliminate any resistant gram positive organisms.
2.2.2 Antibiotics used for SDD of mice:
For selectively eliminating the AGNB from the digestive tract a 
combination of 0.51 mg. of polymyxin E sulphate (Pe), (Sigma), 0.42 mg of 
tobramycin (Tn) (Lilly France S. A. Fegensheim, France, for Eli Lilly and 
company LTD, Basingstoke, England), and 0.86 mg amphotericin B. (E.R. 
Squibb & Sons LTD, Middlesex, England) (SDD regimen) in aqueous 
suspension (PTA), were administered by gavage in a volume of 0.2 ml to each 
mouse onceaday (Speekenbrinketal., 1987; 1988).
Cefotaxime (CTX) (Roussel Laboratories LTD., Uxbridge, England) was 
administered to mice with or without the PTA regimen at a dose of 3 mg 
mouse'1 given by a single intraperitoneal (i.p.) injection each dayfor4days.
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For selectively eliminating the anaerobic normal flora from the digestive 
tract clindamycin (Sigma) was administered to mice at a dose of 0.6 mg. 
mouse'1 given by gavage in a volume of 0.2 ml once a day for 4 days.
2.3 Challenge Strains:
Seven challenge strains were used in the evaluation of CR (Table 6). 
Strains were rendered Sm and Nm resistant by passage in the presence of 
antibiotics, except for E.coli s-R 21 which was made resistant to Nm by transfer 
of plasmid RP4 by Dr. D. Platt (Department of Bacteriology, Royal Infirmary, 
Glasgow, U.K.). E.coli s-R21was derived from mouse faecal flora. Human 
isolates of Proteus mirabilis s-R9 resistant to TDD and SDD regimen, and 
sensitive to CTX, Ps. aeruginosa S-R321, Kl. pneumoniae S-R10, and 
Providencia stuartii s-R7 were kindly donated by Dr. A. B. J. Speekenbrink 
(Department of Bacteriology, Western Infirmary, Glasgow, U.K.). Human 
isolates of clinically drug resistant Ps. cepacia S-R13, and Candida albicans 
s-R5 were kindly donated by Dr. S. R. Alcock (Department of Bacteriology, 
Western Infirmary, Glasgow, U.K.).
2.4 Culture Media:
Brain heart infusion broth (BHIB) (Oxoid .Basingstoke, Hants, U.K.) 
was used for homogenizing the faecal pellets, and as a diluent in all dilution 
procedures. The aerobic flora and the challenge strains were cultured on Mac 
Conkey agar without salt (Oxoid) (MC), and on blood agar base No. 2 (Oxoid) 
plus 5 % defibrinated horse blood (Oxoid) (BA). Pseudomonas selective agar 
(Oxoid) (Ps.S A) was used for selecting and culturing Pseudomonas species, 
Desoxycholate Citrate Agar (DCA) (Oxoid) for culturing Providentia stuartii 
s-R7, and de Man, Rogosa, and Sharpe agar (Oxoid) (MRSA) for isolating 
Lactobacillus species. For culturing Candida albicans s-R5, Sabouraud broth 
(Oxoid), and Sabouraud agar (Oxoid) were used.
The anaerobic flora was cultured using Wilkins-Chalgren anaerobic
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Table 6 Challenge Strains
Species Strain MIC level in mg m l1 Source
Sm Nm Pe Tn
E. coli s-R21 10 10 Mouse
Klebsiella pneumoniae S-R10 0.22 0.1 Human
Pseudomonas aeruginosa S-R321 10 10 Hunam
Proteus mirabilis s-R9 5 2.5 1 0.5 Human
Pseudomonas cepacia S-R13 10 10 Human
Providencia stuartii s-R7 Human
Candida albicans s-R5 Human
Sm: Streptomycin, Nm: Neomycin, Pe: Polymyxin E, Tn: Tobramycin.
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agar (Oxoid) plus 5 % defibrinated horse blood( anaerobic BA), and M 10 agar 
(Caldwell and Bryant, 1966) (see appendix 1).
2.5 Assay of Antibiotic Activity in Murine Faeces and Caecal Content:
Fresh faecal pellets were collected from mice treated with TDD, SDD 
and/or cefotaxime to estimate the concentration or the activity of these drugs 
in murine faeces or caecal contents. The faecal pellets or the caecal content 
were immediately weighed, and homogenized in 3 parts by weight of distilled 
water. The homogenates were centrifuged for 10 minutes at13000RPM using 
a micro-centrifuge (M S E, England, U.K.). The supernatant fluid was removed 
without disturbing the sediment using a syringe, and filtered using a 0.45 /im 
sterile acrodisc syringe filter (Gelman science, Michigan, U.S.A.). A standard 
solution of each antibiotic was prepared before starting the antibiotic assay.
The antibiotic activity was assayed by one of the following 3 procedures:
1) Antibiotic discs were prepared by adding 5 yt\ of the filtered supernatant, 
and of each dilution of the standard on autoclaved paper discs 5 mm in 
diameter. The discs were left to dry at room temparature in a sterile petri dish. 
Sensitivity agar (Oxoid) plates were lawned with an overnight culture of an 
indicator strain. The antibiotic discs were placed on the agar plates, and all 
plates were incubated overnight at 37°C . Four discs of each sample and 
control were used.
2) Sensitivity agar plates were lawned with an indicator organism, and 4 wells 
in each agar plate were made using a 5 mm well punch. The bottom of the 
wells were sealed by adding 8 /il of melted nutrient agar (Oxoid). Aliquots of 
(20 fj\) of supernatant fluid or the standard were added to the wells. The 
plates were incubated overnight at37°C.
3) The faecal pellets were pooled , homogenized, and compressed into 5 x 3  
mm cylindrical pellets. An indicator strain was cultured overnight in BHIB. Blood 
agar base was mixed with an equal volume of BHIB, and cooled to 40°C. The
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overnight culture of the indicator organisms was ten-fold serially diluted in 
BHIB, and 2 ml of the fourth dilution (2 x 105 cells ml'1) was added to the agar, 
which was poured into 30 mm culture dishes (Flow Laboratories) . One 
standardized faecal pellet was placed in the centre of each culture dish, and the 
dishes were incubated overnight at 37°C.
An estimate of antimicrobial activity was determined in each procedure by 
squaring the diameter of the zone of inhibition of bacterial growth. Each 
experiment was performed 4 times.
2.6 Preliminary Experiments:
2.6.1 Stability of streptomycin and neomycin in drinking water:
For testing the stability of Sm and Nm in drinking water at room 
temperature, 1 ml of the drinking water containing Sm and Nm was collected 
daily in an Eppendorf tube, and stored at -70°C until assayed. A standard 
solution of Sm and Nm was prepared before starting the assay by dissolving 6 
mg of each antibiotic in 1 ml of distilled water. Twofold serial dilutions were 
made in distilled water in 50 / i I volumes to give a final concentrations of 
6,3,1.5,0.75,0.38, and 0.19 g T Antibiotic discs were prepared as described in 
section (2.6). Sensitivity agar plates were lawned with an overnight culture of 
E.coli NCTC 10418 or E.coli SmR Nms to test the activity of the combination of 
Sm and Nm , or of neomycin alone respectively.
2.6.2 The level of resistance of the challenge organisms to Sm and 
Nm:
The activity ofSm and Nm in mouse faeces was monitored to indicate 
the minimum level of resistance necessary in a challenge strain during TDD. 
Fresh faecal pellets were collected at 4, 8, 12,16, and 24 hours after 
administration of antibiotics. The pellets were assayed and discs of standard 
solution and of the supernatant fluid were prepared in the same manner as in 
section (2.5). E. coli NCTC No. 10418 was used as an indicator organism.
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2.6.3 Creation of multiple resistant challenge organisms:
E.coli s-R21, Kl. pneumoniae S-R10, Ps. aeruginosa S-R321 and 
Proteus mirabilis s-R9 were passaged in BHIB containing increasing 
concentrations of Sm and Nm and PTA antibiotics. The MIC of these organisms 
was assayed to see if they could be used as challenge organisms for 
evaluation of CR during TDD and SDD treatment. MIC was measured using 
standard procedures
2.7 Evaluation of Colonization Resistance:
Groups of 8 conventional mice were used for each challenge 
experiment. Strains were cultured overnight in BHIB, and then serially ten-fold 
diluted in BHIB. Mice were given 0.2 ml of saturated aqueous sodium 
bicarbonate by gavage, followed by 0.2 ml of one of the dilutions. For 
estimating the total viable counts (TVC) of the culture 20p\ of each dilution was 
cultured on BA and incubated overnight at 37°C.
2.8 Quantification of Colonization Resistance:
CR was expressed as the log of that oral dose of an organism resulting 
in colonization in 50 % of animals for at least 2 weeks (van der Waaij et al., 1971) 
as estimated by presence of the organism in the faeces.
2.8.1 Faecal culture:
For culturing the different challenge strains from mouse faeces, fresh 
faecal pellets were collected in a test tube from individual mice at intervals after 
challenge. The pellets were homogenized in 2 ml of BHIB containing 2 mg ml'1 
of Sm and Nm , and incubated at 37°C . After 24 hours incubation subculture 
was made on to solid media. The media used were MC and BA agar for all 
challenge strains, plus the following selective media: DCA for culturing 
Providencia stuartii s-R7 ,and PsS A for Ps. aeruginosa S-R321, and Ps. 
cepacia S-R13 challenge strains. Sabouraud broth and agar was used to 
culture Candida albicans challenge strains. Mice were removed from the 
experiment if 2 successive negative cultures for the challenge strain were
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obtained. Aerobic normal flora was identified by the colony morphology, 
growth on selective media, gram appearance. For the identification of AGNB 
the API 20 E system (API, Bio Merieux, France) was used in some cases.
2.9 Estimation of Aerobic Faecal Flora:
For monitoring TVC of the aerobic faecal flora, fresh faecal pellets were 
collected in test tubes from individual mice. The pellets were immediately 
weighed, and homogenized in 9 parts by weight of BHIB to make a 1:10 
dilution. Serial tenfold dilutions of the homogenate were made in the same 
broth , and the viable bacteria were estimated using the Miles and Misra 
droplet count (Miles etal., 1938) on duplicate plates of MC and BA. The viable 
count was reported as log o of the CFU per gram of faeces.
2.10 Bacterial Culture of Different Regions of the Intestine:
Mice were sacrificed by cervical dislocation, and dissected on a 
dissecting board under aseptic conditions. The microflora of five parts of the 
gut; the upper jejunum, lower jejunum, ileum, caecum, and colon was 
estimated. Each part of the gut was weighed immediately, 9 parts by weight of 
BHIB were added , and the gut segments were homogenized in a blender. For 
quantitative estimation of aerobic flora, ten fold serial dilutions were made, 
and 20/ilofeach dilution was placed on duplicate plates of BA, MC agar, and 
MRS agar. The same media were inoculated for single colonies of aerobic 
normal flora. For qualitative determination of organisms present in low 
numbers all plates and dilution tubes were incubated at 37° C. After 24 hours 
incubation, subculture was made from the tubes on BA, MC agar and MRS 
agar: the plates were incubated overnight at 37°C.
2.11 Estimation Of Anaerobic Faecal Flora:
Fresh faecal pellets were collected from individual mice in a test tube. 
The pellets were immediately weighed, and moved into an anaerobic chamber
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(iMK3 anaerobic work station, Don Whitiey Scientific Limited, Shipley, West 
Yorkshire, England). The pellets were homogenized in 9 parts by weight of 
reduced BHIB to make a 1:10 dilution. Serial ten-fold dilutions of the 
homogenates were made in the same broth. Aliquots 0.1 ml of the relevant 
dilutions were transferred to the middle of reduced anaerobic BA plates, and 
spread evenly over the surface of the media using a bent Pasteur pipette. Four 
plates of anaerobic BA were used for each dilution, and the plates were 
incubated for 7 days in the anaerobic chamber under anaerobic conditions (5 
% H , 10%CO2, and 85 %N). After incubation the plates were removed from 
the anaerobic cabinet, and different types of colonies were picked and
inoculated on MC and BA, and incubated in air, and in 10 % CO for 24 hours to
2
separate the facultatively anaerobic from the obligate anaerobic colonies. The 
diversity of the anaerobic faecal flora was estimated semi-quantitatively by 
counting the different types of anaerobic colony. Colonies were categorized by 
circumference, elevation, edge, surface, translucency, colour, texture and their 
effect on media.
2.12 Estimation of the Concentration of B-aspartylglycine:
The concentration of 8-aspgly in the faeces was studied using a High 
Performance Liquid Chromatograph (HPLC) {Gilson Medical Electronics, 
Middleton. Wl, U.S.A.). Reverse-phase HPLC was carried out on a spherisorb 
microbore analytical S50DS1 column 250 mm long x 4.6 mm internal diameter 
(id), and an analytical guard column 20 mm long x 2 mm id packed with 
spherisorb SGODS1. Faecal o-phthaldialdehyde (OPT) derivative (20 p\) were 
chromatographed on a 5 mM phosphate buffer pH 6.5: methanol gradient. The 
flow rate was variable between 1 - 2 ml minute'1 (Figure. 2). No appropriate 
internal standards were available, and B-aspgly was identified in faecal 
derivative by comparison with the mobility of 8-aspgly (Sigma) in water (100n 
mole ml'1 stock solution). The OPT reagent solution in a concentration of 1 g I1 
(Sigma) derivatives were detected on an in-linefluorometer with excitation filter
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of 305-395 nm and emission filter of 430-470 nm. The output was recorded on a 
digital integrator {Shimadzu model C-R3A, chromatopac, Dyson instruments 
LTD., Hetton, England).
2.12.1 Preparation of B-aspartylglycine standard:
B-aspartylglycine (Sigma) was stored in small vials in a concentration of
100 n mole m l1 at - 20°C. The standard was prepared by adding OPT to the 
standard in a ratio of 2 :1 respectively (0.1 ml OPT :0.05 ml standard), and 
diluted 1 :5  in distilled water before use. The mixture was allowed to react for 2 
minutes at room temperature.
2.12.2 Preparing the test sample from murine faeces:
Fresh faecal pellets were collected from individual mice in Eppendorf 
tubes before, during, and after treatment with different antibiotics. The pellets 
were immediately weighed, and homogenized in 9 parts by weight of distilled 
water to make 1:10 dilution. The homogenate was centrifuged for 10 minutes 
at 13000 RPM using a micro-centrifuge (M S E, England , U.K.). The 
supernatant fluid was removed using a syringe without disturbing the 
sediments, diluted 1 :5  in distilled water, and filtered using 0.45pm syringe 
filter (Sterile Acrodisc, Gleman science, Michigan, U.S.A). The filtered 
supernatant was then treated in the same manner as the B-aspartylglycine 
standard.
2.12.3 Injection of samples into HPLC machine:
A Hamilton microliter syringe (Hamilton Bonaduz AG, Bonaduz, 
Switzerland) was used for injecting 20 p\ of the samples into the HPLC. The B- 
aspgly standard was injected before, and after injecting and testing a set of 
test samples. The B-aspartylglycine peak in the test sample was identified by 
comparison with the retention time of the B-aspartylglycine peak in the 
standard.
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2.12.4 Estimating the concentration of B-aspgly in test sample:
The concentration of the B-aspartylglycine of test samples was 
calculated using the known concentration of the control sample, and the area 
of the peaks of the control and test samples. The area of the peak was 
estimated by the formula:
Area of the peak = Height x Width at 1/2 Height
2.13 Activity of Antibiotic in Murine Faeces orCaecal Content:
2.13.1 Mice treated with TDD regimen:
The activity of Sm and Nm in mouse faeces in mice treated by gavage or 
ad libitum in drinking water was compared. The faecal pellets were assayed, 
sensitivity agar was lawned with E.coli NCTC No. 10418 and the supernatant 
fluid was added to the wells as described in section (2.5).
2.13.1.1 Effect of TDD regimen in murine faeces on E.coli S-R21 
challenge strain in vitro:
The activity of Sm and Nm in murine faeces on E.coli S-R21 challenge 
strain was studied in vitro. Cylindrical pellets were prepared as described in 
section (2.5) Strains of E.coli NCTC No. 10418 and E.coli S-R21 challenge 
strain were used to observe the zone of inhibition.
2.13.2 Mice treated with PTA regimen:
A standard solution of antibiotics was prepared by dissolving 1 mg 
each of Pe andTn in 1 ml of distilled water. The supernatant fluid was prepared 
as described in section (2.5), and antimicrobial activity in the faeces was 
estimated using E.coli NCTC 10418 as an indicator.
2.13.3 Mice treated with cefotaxime:
2.13.3.1 The concentration of cefotaxime in mouse caecal content:
The mice were dissected and the caecal contents were collected 
aseptically, and assayed for antibiotic activity as described in section (2.5). 
The standard antibiotic solution contained 3 g I'1 CTX, and the indicator strain
80
was E.coli NCTC 10418.
2.13.3.2 In vitro effect of CTX in murine faeces on aerobic 
organisms:
The activity of CTX in murine faeces on the CTX sensitive organisms, 
E.coli s-R21 ,Ps. aeruginosa s-R32'\, anti Proteusmirabilis s-R9was studied. 
Agar lawned with one of these strains prepared as described in section (2.5). 
Neomycin (1 mg ml'1) was added to the agar. Cylindrical pellets were used to 
observe the activity of CTX as described in section (2.5).
2.13.3.3 In vitro effect of CTX in mouse caecal content on the 
anaerobic flora:
The activity of CTX in mouse caecal content on the anaerobic normal 
flora was tested in vitro. Supernatant fluid from mouse caecum was obtained as 
described in section (2.5). Anaerobic BA was lawned in an anaerobic cabinet 
with 0.01 ml of homogenized faecal suspension. Wells were made in agar as 
described in section (2.5), and 20 fj\ of the samples were added to the wells. 
One well contained CTX (20 fj\) at 3 mg m l1 as a positive control. All plates 
were incubated for 5 days at 37°C in the anaerobic cabinet.
2.13.3.4 The in vitro effect of CTX on the anaerobic faecal flora:
The lowest concentration of CTX which affected the anaerobic faecal
flora was determined in vitro. Two fold serial dilutions of 3 g I1 of CTX were 
made using the same procedure described as in section (2.5). A n aliquot (20 
/il) of each dilution was added to wells in agar plates lawned with 0.01 ml of 
faecal suspension. The plates were incubated for 5 days at 37°C in the 
anaerobic cabinet, after which the zones of inhibition were estimated.
2.14 Statistics:
All statistics were calculated using an in-house computer program, the 
significance of the differance between means was estimated using a two- 
sample Student's t test.
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Chapter Three
RESULTS
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3. Results:
3.1 Results Of Preliminary Experiments:
3.1.1 Recovery of E.coli and enterococci after antibiotic treatment:
One group of 18 mice was treated for two weeks with TDD antibiotics 
(Sm, Nm) given ad libitum in drinking water. Mice were caged individually, and 
kept in a clean isolated room. No E.coli or enterococci were isolated from the 
faeces during the treatment period. However, in 2 / 1 8  mice small colonies of 
lactose fermenters were seen growing on MC agar and on BA during treatment. 
From a gram stain it was seen that these organisms were gram positive bacilli 
with terminal spores morphologically similar to Clostridia.
One day after cessation of treatment only 3/18 mice showed growth of 
Lactobacillus species on MRS agar, and no other aerobic organisms were 
detected. By day 5 after cessation of treatment, all mice showed growth of 
lactobacilli, and 9 / 1 8  mice showed growth of Bacillus species on BA. 
However, no E.coli or enterococci were detected 4 weeks after cessation of 
treatment. Even when 8 of these mice were housed together in one cage and 
moved to a room with conventional mice for 10 days , they failed to colonize 
with E.coli or enterococci. However, when treated mice were co-housed with a 
group of 8 conventional mice in one cage, they became colonized with 
enterococci, but no E.coli was detected during the 2 weeks of co-housing.
Before treatment and on day 5, 7, 11, 14, and 28 after cessation of 
treatment, 2 mice were sacrificed, dissected, and the microflora of 5 parts of the 
gut (upper jejunum, lower jejunum, ileum, caecum, and colon) was estimated as 
described (materials and methods 2.10). In control mice lactobacilli, and 
Bacillus species were isolated from all 5 parts of the gut, whereas E.coli and 
enterococci were isolated only in the ileum, caecum, and colon. In TDD 
treated mice no E.coli or enterococci were detected in any part of the gut
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during the 4 weeks after cessation of treatment. However, Lactobacillus 
species, and Bacillus species were detected in the gut of all mice.
3.1.2: The stability of streptomycin and neomycin in drinking water:
The stability of the combination of Sm and Nm as TDD antibiotics in 
drinking water at room temperature was estimated as described (materials 
and methods 2.6.1). The activity of the combination of Sm and Nm in drinking 
water was stable for the first 5 days. It was observed that this activity was 90 % 
of the original activity after 5 days, and it had decreased to 38 % by day 6.
The same result was obtained when only Nm was tested using SmR 
NrrfE.coli . The activity of Nm dropped from 82 % on day 5 to 31 % by day 6 
and remained the same until day 14, which was equivalent to the last day of 
TDD treatment (Figure. 3).
3.1.3 The level of resistance of the challenge organisms toSmand
Nm:
One group of 10 mice was treated with one dose of0.24mgeachofSM 
and Nm given by gavage. Faecal pellets were collected from the mice 4,8,12, 
16, and 24 hours after administration of antibiotics. The highest antibiotic 
activity of the combination of TDD antibiotics in faecal pellets was seen 4 hours 
after treatment. By comparing the zone of inhibition of E.coli NCTC 10418 by 
TDD antibiotics in faecal pellets at 4 hours after treatment to the zone of 
inhibition of standard concentration of Sm and Nm, it was observed that 
organisms had to be resistant to at least 10 mg ml'1 each of Sm and Nm to be 
used as a challenge strain during treatment with TDD antibiotics.
3.1.4 Effect of the mode of administration ofTDD regimen onCR:
Four groups of 8 mice were treated for 2 weeks with Sm and Nm. Two of 
these groups were treated with 10 mg mouse'1 each of Sm and Nm given by 
gavage, where the other two groups were treated with 5 mgml1 of each Sm and
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Figure 3 The activity of Sm and Nm in drinking water at room temprature 
during 14 days.
*  of indicator strains : E. coli NCTC No. 10418 for testing the activity of the 
combination of Sm and Nm, and SmR Nms E. coli for testing the the activity of 
Nm alone.
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Nm given ad libitum in drinking water. On the second day of treatment the two 
groups of each category were challenged with 102 and 103cfu of E.coli S-R21 
challenge strain respectively. In mice which were treated by gavage 3 /8  mice of 
each group lost the challenge organisms during treatment (Figure. 4). All mice 
were colonized for over 2 weeks after treatment when given antibiotics ad 
libitum in drinking water.
3.1.5 Comparison of two media for the enumeration of anaerobic 
faecal flora:
Anaerobic BA and M 10 agar were compared for the enumeration of 
anaerobic faecal flora. The TVC of anaerobic flora on AN02 BA was higher by 
0.5+ 0.2 log cfu than on M 10 agar. On this basis, and the greater ease with
which colony types could be distinguished on ANO BA, it was decided to use
2
this medium throughout this study.
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3.2 Studies On Faecal Pellets:
Faecal pellets from batches of mice were subjected to direct gram film 
and microscopy, aerobic culture, anaerobic culture, and in some cases 6- 
aspartyglycine analysis Table. 7.
3.2.1 Faecal pellets/Direct Gram films:
3.2.1.1 Control mice: (256 mice)
The gram stain showed a complex mixture in the range of 1 6 - 2 0  
different organisms. A representative gram film is shown in Figure 5.
3.2.1.2 Wild mice: (3 mice)
The gram stain showed a complex mixture in the range of 12 -16 different 
organisms mainly short gram negative bacilli, short fat gram positive bacilli, 
tapered rods, fusiform, and gram negative cocci.
3.2.1.3 Mice treated with TDD regimen: (184 mice)
No organisms were seen on gram film of faeces during treatment of 
7/23 groups of 8 mice treated with the TDD regimen . Sixteen other groups of 
mice showed two types of organisms; gram positive bacilli with terminal spores, 
and short fat gram positive bacilli. These organisms are probably the same as 
those seen on culture (results section 3.3.2.3). By day 7 after treatment a more 
complex mixture of organisms was seen, but the gram film was not as complex 
as samples from control mice.
3.2.1.4 Mice treated with SDD regimen:( 104 mice)
After one dose of treatment with PTA the large gram negative bacilli 
(GNB) seen in control mice (Figure. 5) were not detected (Figure. 6). No 
further changes were seen after 5 days of treatment (Figure. 7). Seven days 
after cessation of treatment, the diversity of the flora was similar to that of 
control mice (Figure. 8).
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Figure 5 Gram film of faecal flora of untreated control mice.
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Figure 6 Gram film of faecal flora of mice after one dose of PTA antibiotics. 
(Notice the disappearance of the large gram negative bacilli 
shown in gram film of control mice (Fig. 5))
90
Figure 7 Gram film of faecal flora of mice on day 5 during PTA regimen.
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Table 7 Total number of mice used in each test analysis.
Test Analysis Total No. of Mice* No. of Groups
Gram Stain 635 79 Of 8
Aerobic Culture 451 56 Of 8
Anaerobic Culture 427 53 Of 8
B-aspartylglycine 47 11 Of 4
*  Total number of mice including 3 wild mice.
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3.2.1.5 Mice treated with cefotaxime: (32 mice)
A simplification of the normal flora was seen. Only gram positive cocci 
and 2 - 3 types of gram positive bacilli were present during treatment (Figure. 
9). A more complex mixture of organisms was seen 2 -3  days after treatment, 
which is probably due to the recovery of large GNB, tapered rods, fusiforms, 
and other GNB.
3.2.1.6 Mice treated with PTA regimen with addition of systemic 
cefotaxime: (40 mice)
A simplification of the normal flora was seen. Only gram positive cocci, 
and three types of gram positive bacilli (Figure. 10) were present during 
treatment with PTA and cefotaxime. Some types of GNB did recover after 
stopping cefotaxime, during continued treatment with the SDD regimen 
(Figure. 11). A gram film from one day after cessation of all treatment showed 
a more complex mixture of organisms (but less than control mice) (Figure. 12) 
than during treatment.
3.2.1.7 Mice treated with Clindamycin: ( 16 mice)
A simplification of the faecal flora occurred, and only gram negative
bacilli were seen in large numbers during treatment (Figure. 13). One day after 
cessation of treatment gram negative cocci, large GNB and short GNB were 
seen, whereas the GPB were first seen 3 days after cessation of treatment.
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Figure 8 Gramfilm offaecalflora of mice 7 days after cessation of PTA 
regimen. (Notice the recovery of the fusiform bacteria, and 
other gram negative rods).
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Figure 9 Gram film offaecal flora of mice after one dose of cefotaxime. 
(Notice the simplification of the normal flora compared to 
control mice (Fig. 5)).
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Figure 10 Gram film of faecal flora of mice after one dose of PTA antibiotics 
with addition of cefotaxime. (Notice the simplification of the 
flora compared to control mice (Fig. 5)).
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Figure 11 Gram film offaecal flora of mice after stopping cefotaxime, during 
9 days of treatment with PTAregimen. (Notice the recovery of 
GNB).
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Figure 12 Gram film of faecal flora of mice one day after cessation of 
treatment with PTA antibiotics with addition of cefotaxime. 
(Notice the recovery of most of faecal flora compared to 
during treatment (Fig. 10)).
'Jk 
y
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Figure 13 Gram film offaecal flora of mice 3 days during treatment 
with clindamycin. (Notice the simplification of the normal 
flora and the elimination of all gram positive organisms).
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3.2.2 Faecal pellets/Aerobic culture:
3.2.2.1 Control mice: (9groups of 8 untreated mice)
Faecal pellets from untreated mice of different batches were used to 
monitor the normal flora of the gut, as described in materials and methods. The 
total viable count, and colony types of aerobic faecal flora in control mice 
varied. The mean T V C was( 7.3+^ 0.08 log cfu / g of faeces). The flora consisted 
mainly of E.coli (5.8 + 0.2 log cfu /g  offaecal pellets), enterococci (6.9 _+ 0.1 log 
cfu / g of faeces), small numbers of lactose non-fermenting organisms, and 
Bacillus sp. (Table. 8).
Swarming Proteus sp. and Klebsiella oxytoca were isolated from some 
mice in only 3 of the 9 groups of 8. It was not possible to isolate Pseudomonas 
aeruginosa, Klebsiella pneumoniae, or Candida albicans from the faecal flora of 
the 72 control mice.
3.2.2.2 Wild mice:
Only E.coli was isolated from the three wild mice. The total viable count 
was 6.7 log (cfu / g of faeces). No other aerobic organisms were isolated except 
lactose non-fermenting gram positive bacillus from one mouse (Table. 8).
3.2.2.3 Mice treated with TDD regimens: (23 groups of 8 mice)
Mice from different batches were treated for two weeks with TDD 
antibiotics given ad libitum in drinking water, as described in materials and 
methods. After one day of treatment no aerobic flora was detected, and 
anaerobic bacteria did not reappear during the treatment period (Table. 8). In 
16 groups of 8 mice small colonies of lactose fermenters were seen growing on 
McConkey agar, and on blood agar throughout treatment at a TVC of (9 jf  0.2 
log cfu / g of faeces). A gram stain showed these to be gram positive bacilli with 
terminal spores morphologically similar to Clostridia.
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Table 8 The effect of different antibiotics on the aerobic
flora in Batb / c mice.
Treatment No. of mice E.coli
% of mice meancfu' 
carrying
Enterococci 
% of mice meancfu' 
carrying
Control 72 100 5.8+0.2 100 6.9+0.1
Wild mice 3 100 6.7 0 —
TDD 184 0 0 —
PTA 104 0 100 6.5+.2
CTX 32 0 100 9+0.5
PTA+CTX 40 0 100 9.1 +0.3
Clindamycin 16 100 9.4+0.2 0 —
*log + SE.
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The recovery of most aerobic bacteria after treatment with TDD regimens 
varied in mice from different batches. In 70 % of the cases the recovery of 
aerobic flora was slow. When kept in a clean environment to avoid the risk of 
contamination, mice were not recolonized with E.coli for three weeks or more 
after treatment. By contrast, enterococci recovered by 5 - 7 days after treatment.
3.2.2.4 m ice treated with SDD: (13groups of 8 mice)
Mice from different batches were treated for two weeks, with the PTA 
given by gavage. After one dose, E.coli and other aerobic gram negative bacilli 
could not be detected, and E.coli did not reappear for two weeks after stopping 
treatment (Table. 8). No significant changes were seen in the total viable count 
of enterococci during treatment and after treatment.
3.2.2.5 Mice treated with cefotaxime: (4 groups of 8 mice)
Mice from different batches, were treated for four days with 3 mg day1 of 
cefotaxime, given by i.p. injection. After one dose of cefotaxime, E.coli could 
not be detected, and it had not reappeared two weeks after stopping treatment 
(Figure. 14). At the same time a significant (P < 0.02) increase of 1.1 -H 0.6 log 
(cfu) occurred in the total viable count of enterococci. In each case, the total 
viable count of enterococci returned within three days after treatment to that 
measured in the same mouse before treatment (Figure. 15).
3.2.2.6 Mice treated with SDD regimen with addition of systemic 
cefotaxime: (5 groups of 8 mice)
Mice from different batches were treated with PTA given by gavage, with 
the addition of 3 mg per day of cefotaxime given by i.p. injection. After one dose 
oftreatmenttheE.coli could not be detected, and they had not reappeared two 
weeks after stopping the treatment. The total viable count of enterococci was 
significantly (P < 0.009) increased by 2.6 Hh 0.4 log (cfu) during treatment with
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PTA plus cefotaxime (Table. 8). In each case, the total viable count returned 
after treatment to that measured in the same mouse before treatment (Figure. 
16).
3.2.2.7 Mice treated with clindamycin: (2 groups of 8 mice)
Two groups of mice were treated for four days with 0.6 mg per day of 
clindamycin, given by gavage. After one dose of clindamycin the TVC of E.coli 
significantly (P< 0.008) increased by 3.5+^ 0.6log (cfu), and remained at the 
same level during the treatment period. In2-3daysafter stopping treatment, 
the TVC of E coli was similar to that measured in the same mice before 
treatment (Figure.17).
The enterococci were reduced to anon detectable level during the 
treatment period, and they recovered to the normal level one day after 
treatment was stopped (Table. 8).
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3.2.3 Faecal pellets/Anaerobic culture:
3.2.3.1 Control mice: (6 groups of 8 untreated mice)
The total viable count of anaerobic faecal flora varied in different groups 
of mice. The mean TVC was 10.5 + 0.06 log (cfu / g of faecal pellets). The 
growth on anaerobic media showed 12 ■+ 1 different colony types (Figure. 18) 
at a dilution of 10'7, which mainly consisted of spore-forming gram positive 
bacilli, fusiform bacteria, gram positive cocci, gram negative cocci, gram 
negative bacilli and non spore forming gram positive bacilli.
3.2.3.2 Wild mice: (3 mice)
The total viable count of the anaerobic flora in the wild mice was 9.8 log 
(cfu / g of cecum content), which consisted of 8 -10 different colony types at a 
dilution of 10'7. Gram morphology was almost similar to that of control mice.
3.1.3.3 Mice treated with the TDD regimen: (23 groups of8 mice)
After one day of treatment with the TDD antibiotics no organisms were
detected on anaerobic culture in 7 out of 23 groups of 8 mice, and they did not 
reappear during the 14 days of treatment. Residual anaerobes were detected in 
16/23 other groups of 8 mice despite the TDD regimen: two types of colonies 
were observed on blood agar under anaerobic conditions. These were gram 
positive bacilli with terminal spores, and short gram positive bacilli. These 
probably were the aerotolerant Clostridia observed earlier (results section 
3.2.2.3), The total viable number of these organisms was 9 + 0.2 log (cfu / g of 
faeces) during treatment; this decreased to 6.9 +_ 1.4 log (cfu / g of faeces) 2 - 3 
days after stopping treatment (Table. 9).
The recovery of anaerobic flora after stopping treatment was slow; seven 
days after treatment only 4 + 1  types of colonies were seen in 18 groups of 8 
mice. Two weeks after treatment the mean total viable count was (10.35 + 0.2
108
Figure 18 Anaerobic faecal flora ofcontrol mice at a dilution of 107 on 
anaerobic blood agar.
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T ab le  9 The effect of different antibiotics on the anaerobic total 
count and diversity of faecal flora of B a lb /c  mice.
Treatment No. of 
mice
% of mice 
carrying
No. of colony types 
at a 10 7 ditutionof 
faeces
mean cfu*
Control 48 100 10-14& 10.5 + 0.1
Wild mice 3 100 8-10 9.8
TDD 184 70 2 9+0.2
PTA 104 100 8-12 10.9+0.2
CTX 32 100 2 -4 10.8+0.13
PTA + CTX 40 50 1 -2 9+0.8
Clindamycin 16 0 — —
& Range.
* log + SE.
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log cfu / g of faecal pellets), and only 6 + 1 types of colonies were recovered 
compared to 12 +_ 1 types for control mice at a dilution of 10'7.
3.2.3.4 Mice treated with SDD regimen: (13 groups of8mice)
The total viable number of anaerobic faecal flora was not affected 
significantly; an increase of 0.66 hh .2 log (cfu) was seen in 7 groups of 8 mice 
during treatment with the SDD regimen. One day after treatment, the total viable 
count of the anaerobic flora returned to the same level as control mice. 
Simplification of the anaerobic flora types was observed (Figure. 19). This was 
associated with significant reduction in the colony types of anaerobic gram 
negative rods.
3.2.3.5 Mice treated with cefotaxime: (4 groups of 8)
After one dose of cefotaxime, a simplification of the anaerobic flora 
occurred in 4 groups of 8 mice. Growth on blood agar at a dilution of 107 
showed a reduction from 12 Hh 1 different colony types for mice before 
treatment, to only 3 ■+ 1 types for the same mice treated with cefotaxime. The 
total viable count of anaerobic flora did not change significantly (Table. 9). This 
may be due to an increase in the numbers of the remaining anaerobic 
organisms in the gut, which consisted mainly of gram-positive spore-forming 
bacilli. Some types of anaerobic flora did recover during the treatment period; 
an increase of 5^1 colony types was observed. A full recovery of diversity was 
seen 2 - 3 days after treatment.
3.2.3.6 Mice treated with PTA with the addition of systemic 
cefotaxime: (5 groups of 8 mice)
After one dose of treatment a simplification in the anaerobic normal flora 
occurred; growth on blood agar at a dilution of 10'7 showed reduction from 
12+1 different colony types, to only 1 or 2 types for the same mice treated with 
SDD regimen with addition of systemic cefotaxime (Figure. 20). In 50% of total
I l l
Figure 19 Simplification of colony types of anaerobic faecal flora on 
anaerobic blood agar after one dose of PTA antibiotics at 
a dilution of 107.
1 1 2
Figure 20 Simplification of colony types of anaerobic faecal flora of mice 
on anaerobic blood agar after one dose of PTA antibiotics with 
addition of cefotaxime, at a dilution of 107.
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treated mice, the anaerobic flora was reduced to a non-detectable level. The 
total viable count was reduced by 0.9 j-  0.08 log (cfu /got faeces) (Table. 9).
After discontinuation of cefotaxime treatment some components of the 
anaerobic flora began to recover and 5 +■ 1 different types of colonies were 
isolated on blood agar. Seven days after treatment the anaerobic population 
had recovered and the total viable count had returned to the same level as 
before treatment.
3.2.3.7 mice treatment with clindamycin:(2 groups of 8 mice)
After one dose of clindamycin, the anaerobic flora could not be detected. 
One day after treatment some of the anaerobicflora had recovered. By five days 
after treatment the mean total viable count of anaerobes was 10 +_ 0.2 log (cfu / g 
of faecal pellets), which was similar to that of control mice (Figure. 21). A 
simplification of the anaerobicflora was observed; only 5 +_ 1 colony types were 
seen on anaerobic blood agar at a dilution of 10'7 compared to 12 +_ 1 types for 
the same mice before treatment.
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3.2.4 Faecal pellets/ B-aspartylglycine:
Faecal pellets from groups of four mice were collected, prepared, and 
assayed by H.P.L.C. for the presence of 6-aspgly. 6-aspgly was identified in 
faecal OPT-derivative by comparison with the mobility standard OPT-6-aspgly 
in water as described in materials and methods 2.12.
3.2.4.1 Control mice: (6 groups of4untreated mice)
6-aspgly was not detected in the faecal pellets of 24 control, untreated 
mice from different batches.
3.2.4.2 Wild mice: (3 mice)
No 6-aspgly was detected in the cecum content of 3 wild mice.
3.2.4.3 Mice treated with the TDD regimen: (4 mice)
The individual level of 6-aspgly on selected days of experiment is shown 
in Figure. 2 2 . 6-aspgly was not detected in the faeces before treatment. During 
treatment 6-aspgly was present, and by day fourteen of treatment the mean 
concentration in the 4 mice was 329+40 n mole per gram of faecal pellets. Two 
weeks after the end of treatment there was no significant reduction in 6-aspgly in 
2 mice, a moderate reduction in 1 mouse, and no detectible levels in the fourth 
mouse. This finding coincided with the incomplete recovery of anaerobic 
bacteria at this time (results section 3.2.3.3),
3.2.4.4 Mice treated with the SDD regimen: (4 mice)
The individual level of 6-aspgly in 4 mice before, during, and after 
treatment period is shown in Figure. 23. During the treatment period 6-aspgly 
was present, and the mean concentration was 226+28 n mole per gram of 
faecal pellets. This level started to decrease one day after the end of treatment 
and it could not be recovered thereafter from one mouse. By day seven after 
treatment it decreased to a non detectable level in another mouse, and an 
apreciable concentration, 24 n mole and 56 n mole, was detected in the other
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Figure 22 Effect of TDD antibiotics on the present of (3-aspartylglycine 
in Balb/c.
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Figure 23 Effect of PTA antib io tics on the presence of 6-aspartylg lycine
in 4 B a lb /c .
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two mice respectively. This was associated with the recovery of the anaerobic 
tapered rods, fusiform, and other gram-negative bacilli by day 5 after the end of 
treatment (Figure. 7 and 8).
3.2.4.5 Mice treated with cefotaxime: (4 mice)
The level of B-aspgly on selected days of experiment is shown in Figure.
24. B-aspgly was not detected in mice before treatment. During the treatment 
period B-aspgly was present, and the mean concentration was 189+56 n mole 
per gram of faecal pellets. This level started to decrease after treatment, and in 2 
out 4 mice it decreased to a non detectable level one week after treatment. This 
was associated with a recovery of anaerobic flora.
3.2.4.6 Mice treated with SDD regimen with addition of systemic 
cefotaxime: (4 mice)
The level of B-aspgly on selected days of experiment is shown in Figure.
25. No B-aspgly was detected in mice before treatment. During the treatment 
period B-aspgly was present, and by day five during treatment the mean 
concentration was 233+29 n mole per gram of faecal pellets in different mice. 
By day nine of treatment B-aspgly was not detected in 1 of 4 mice. One week 
after treatment B-aspgly was still present, eventhough the diversity of 
anaerobicflora had recovered ( results section3.2.3.6).
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3.3 Colonisation Resistance:
Groups of eight mice from different batches were used in 79 different 
challenge experiments. Colonization resistance was expressed as log of that 
oral dose of an organism resulting in colonization in 50% of animals for at least 
2 weeks ( Van der Waaijet. a!., 1971) as estimated by presence of the organism 
in the faeces.
3.3.1 Control mice: (32 groups of 8 mice)
Mice were challenged by gavage with different doses of each of 7 
different challenge organisms. An oral challenge of 10a' 8 cfu of the E.coli S-R21 
challenge strain was required to achieve intestinal colonisation in over 50 % of 
control mice for over two weeks (Figure. 2 6 ) . The mean total viable count of 
E.coli s-R21 challenge strain in the colonized mice varied between 106 and 108 
cfu / gram of faeces during the 14 days after succesful challenge (Figure. 27). 
By contrast, the faeces of uncolonized mice contained no detectable challenge 
organisms three or more days after challenge.
Colonization of control mice with selected strains of Proteus mirabilis 
s-R9, Pseudomonas aeruginosa S-R321, Pseudomonas cepacia S-R13, 
Klebsiella peumoniae S-R10, Providencia stuartii s-R7, and Candida albicans 
s-R5 was not achieved at challenge doses of 108to cfu (Figures. 28,29,30,31, 
32, and 33). However, the clearance of challenge organisms did vary both 
between organisms and between different mice subjected almost to the same 
challenge (Table. 10).
As expected the control mice had a high colonization resistance. The 
challenge organisms, and doses at which they failed to colonize the gut of 
control mice are shown in (Table. 11).
mi
ce
 
ex
cr
et
in
g 
the
 
ch
al
le
ng
e 
or
ga
ni
sm
s 
(%
)
122
100
■ \
80
60
40
0 2 4 6 8 10 12 14
days after challenge
challenge dose log (cfu)
5.1 5.3 5.9 7.9 8.7 8.9 9
□ ■ A •
Figure 26 Excretion of £.co//s-R21 challenge strain by 7 groups of 8 control 
untreated mice.
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Figure 27 The total viable count of E.co//S-R21 challenge strain in faeces of 
control mice.
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Figure 28 Excretion of Proteus m irabilis  s-R9 challenge strain by group  of 8
contro l untreated mice.
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Figure 29 Excretion of Pseudom onas aeri/g/nosas-R321 challenge strain by
5 groups of 8 contro l untreated mice.
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Figure 30 Excretion of Klebsie lla  pneum oniae s-R 10 challenge strain by 4
groups of 8 contro l untreated mice.
mi
ce
 
ex
cr
et
in
g 
the
 
ch
al
le
ng
e 
or
ga
ni
sm
s 
(%
)
127
100
80
60
40
20
days after challenge
challenge dose log (cfu)
Figure 31 Excretion of Pseudom onas  cepac/'as-R 13cha llengestra in  by 2
groups of 8 contro l untreated mice.
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Figure 32 Excretion o iP roved inc ias tua rtii s-R7 challenge strain by 2 groups
of 8 contro l untreated mice.
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Figure 33 Excretion of Candida a lb icans  s-R5 challenge strain by 2 g roups
of control untreated mice.
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T ab le  10 Examples of % of mice4 excreting the challenge organism.
Challenge Challenge Days
Organism Dose' 1 3 5 7
Proteus mirabilis 9.1 100 77.5 77.5 0
Ps. aeruginosa 8.9 100 12.5 12.5 0
Kl. pneumoniae 9.3 100 100 0 0
Ps. cepacia 9.2 50 50 0 0
Providencia stuartii 9 0 0 0 0
Candida albicans 8.5 100 100 62.5 0
& Groups of 8 mice.
*log  (cfu).
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Tab le  11 Species that were not recovered from faeces two weeks
after challenge.
Challenge Organisms Number of Highest Dose log
Experiments* ( cfu / mouse)
Proteus mirabilis s-R9 7 10
Ps. aeruginosa S-R321 5 10
Kl. pneumoniae S-R10 4 10
Ps. cepac/'as-R13 2 9.2
Providencia stuartii s-R7 2 10
Candida albicans s-R5 2 8.5
*  G roups of 8 mice.
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3.3.2 Mice treated with TDD regimens: (23 groups of 8 mice)
Mice from different batches were treated for two weeks with the TDD 
antibiotics given ad libitum in drinking water. Mice were challenged by gavage 
on the second day of treatment, and one day and 14 days after cessation of 
treatment.
3.3.2.1 Challenging mice during TDD treatment:
3.3.2.1.1 E.coli s-R21: (6  groups of 8 mice)
Residual anaerobic bacteria were detected in 4 / 6 groups of mice after 
one dose of the TDD antibiotics, and were present thereafter: two types of 
anaerobic gram positive bacilli were isolated from in the faeces. On the second 
day of treatment all six groups of mice were challenged by gavage with 1.6 ,3.1,
3.8,4.7,6 .1 and 8 .1 log (cfu) respectively of E.coli S-R21.
All mice were colonized during treatment, and continued to be colonized 
up to the time when monitoring was stopped i.e. at least two weeks after 
treatment. The mean total viable count of the challenge organisms increased to
8.8 +_ 0.3 log (cfu) during treatment, then dropped by 2 - 3 logs after stopping 
treatment, where the fall was variable between the different groups of mice 
(Figure. 34).
3.3.2.1.2 Pseudomonas aeruginosa S-R321: (5 groups of 8 mice)
Total decontamination was not achieved in 3 / 5 groups of mice during
treatment with the TDD antibiotics: two types of residual anaerobic gram 
positive bacilli were present in the faeces. On the second day of treatment these 
3 groups of mice were challenged with 3.1, 6.1, and 7.7 log (cfu) of 
Pseudomonas aeruginosa S-R321. All mice lost the challenge organisms in less 
than one week.
The 2 groups of totally decontaminated mice were challenged on day 
two of treatment with.3.7 and 7.7 log (cfu) of Pseudomonas aeruginosa S-R321.
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Figure 34 The total via ble count of£. coli s-R21 challenge strain in mouse 
faeces during and after treatment with TDD antibiotics. Result 
shown + standard error of mean.
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6 out of 8 mice lost the challenge organisms by day ten during treatment when 
given 3.7 log (cfu) of Pseudomonas aeruginosa S-R321 (Figure. 35). Six out of 
eight mice were colonized for over two weeks when given 7.7 log (cfu). It was 
not possible to colonize control mice when these were given 10 log (cfu) of 
Pseudomonas aeruginosa S-R321 see (section 3.3.1)).
The loss of the challenge organisms from mice with residual anaerobic 
flora was thus faster than from totally decontaminated mice. In contrast, partial 
retention of anaerobic flora did not have any observed effect on colonization by 
E.coli of mice during treatment see (section 3.3.2.1.2),
3.3.2.2: Challenge of mice one day after the end of treatment:
3.3.2.2.1 £.co//s-R21: (3 groups of 8 mice)
One day after treatment with the TDD regimen three groups of mice were 
challenged with 1.3, 5, and 8.8 log (cfu) of E.coli S-R21 given by gavage. None 
of these mice were totally decontaminated during treatment (see section 
3.3.2.1.1). All mice were colonized with the challenge organisms for over two 
weeks, and no loss occurred (Figure. 36). The total viable count of the 
challenge E.coli s-R21in the gut is shown in (Figure. 37); they increased or 
decreased almost to the same level in all an all groups of m ice.
3.3.2.2.2 Pseudomonas aeruginosa S-R321: (1 group of 8 mice)
One day after treatment one group of 8 totally decontaminated mice was
challenged with 7.3 log (cfu) of Pseudomonas aeruginosa S-R321. All mice lost 
the challenge organisms in less than one week (Figure. 36).
3.3.2.3 Challenge of mice two weeks after the end of treatment:
3.3.2.3.1 Treatment with TDD antibiotics only: (5 groups of 8 mice)
Total decontamination was not achieved in 3 / 5 groups of mice see 
(section 3.3.2.1.1). To eliminate residual organisms from the gut, the partially 
decontaminated mice were treated for 3 days with 8 mg of bacitracin per day
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Figure 35 Excretion oi Pseudomonas aeruginosa s-f{32^ challenge strain 
by groups of 8 mice challenged during treatment with the TDD 
antibiotics.
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Figure 36 Excretion of E.coli S-R21 and Pseudomonas aeruginosa S-R321 
challenge strain by 4 groups of 8 mice challenged one day after 
cessation of treatment with the TDD antibiotics.
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Figure 37 The total viable count of E.coli S-R21 challenge strain in mouse 
faeces following challenge 1 day after cessation of treatment with 
the TDD antibiotics. Results shown + standard error of mean.
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given by gavage started on day 5 of the TDD treatment. The residual organisms 
were then reduced to a non detectable levels, but reappeared three days after 
bacitracin treatment was stopped, even though treatment with TDD antibiotics 
was continued.
Two weeks after stopping all treatment all 5 groups of mice were 
challenged by gavage with 3.8, 4.2, 6.8, 8.2, and 8.8 log (cfu) of E.coli S-R21 
respectively. Over 50 % of mice were colonized for over two weeks when 
challenged with 4 log (cfu) or more, and over 50 % lost the challenge 
organisms when challenged with less than 4 log (cfu) of E.coli S-R21 (Figure. 
38).
3.3.2.3.2 Treatment with TDD antibiotics with addition of 
bacitracin: (3 groups of 8 mice)
Mice were treated for two weeks with the TDD antibiotics and 3 mg ml'1 
of bacitracin in drinking water. Mice were not totally decontaminated, Residual 
organisms see (section 3.3.2.1.1) were present during treatment in all mice.
Two weeks after treatment, mice were challenged with doses 3,5, and 8 
log (cfu) of E.coli S-R21. The colonization resistance was almost the same as in 
the other groups of mice which were treated only with the TDD regimens 
(Figure. 38). Over 50 % of mice were colonized for over two weeks when 
challenged with 5 log (cfu) or more, and over 50% of mice lost the challenge 
strain of E.coli in less than two weeks when given less than 5 log (cfu) of E.coli 
S-R21.
Summary of the values of CR is shown in Table 12 p.176.
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Figure 38 Excretion of £.co//s-R21 challenge strain by 8 groups of 8 mice 
challenged 2 weeks after cessation of treatment with the TDD 
antibiotics.
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3.3.3 Mice treated with SDD regimens: (13 groups of 8 mice)
Mice from different batches were treated with the SDD regimen given by 
gavage. As it proved impossible to employ the same strain of E.coli s-R21 
because of lack of appropriate resistance to PTA drugs, mice were challenged 
before, during and after treatment with the SDD regimen with various doses of 
Proteus mirabilis s-R9 resistant to PTA.
3.3.3.1 Mice challenged duringSDD: (4 groups of 8 mice)
Mice were treated for two weeks with the SDD regimen. On day five of 
treatment, when SDD was fully established, mice were challenged with 5.7,6.7,
7.7,8.5 and 8.8 log (cfu) of Proteus mirabilis s-R9 challenge strain respectively. 
More than 50 % of mice lost the challenge organisms in less than two weeks 
after challenge with doses of less than 8 log (cfu) (Figure. 39). Over 50 % of 
mice were colonized for two weeks following challenge with more than 8 log 
(cfu).
The total viable count of the challenge strain of Proteus mirabilis s-R9 was 
reduced from 6.8 + 0.3 log (cfu) during treatment, to 4 +_ 0.2 log (cfu) 5 days 
after treatment. Seventy five percent of colonized mice lost the challenge 
organisms by day 14 after cessation of treatment.
The colonisation resistance for mice treated with the SDD regimens was 
impaired, as was represented by a small but significant reduction in 
colonisation resistance compared to control mice challenged with Proteus 
mirabilis s-R9 (section 3.3,1).
3.3.3.2 Mice challenged after SDD: ( 6 groupsof8 mice)
Mice were divided into 4 categories depending on length of treatment, 
and the challenge day after cessation of treatment.
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Figure 39 Excretion of Proteus m irabilis  s-R9 challenge strain by 5 g roups
of 8 m ice challenged on day 5 during 2 weeks trea tm ent w ith the
PTA regimen.
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3.3.3.2.1 Challenged one day after treatment: { 3 groups of 8 mice)
Mice were treated for 5 or 10 days with the SDD regimen, and challenged
one day after the end of treatment..
A) Five days Treatment: (2 groups of 8 mice)
Mice were treated for five days with the SDD regimen and challenged one 
day after treatment. All mice lost the challenge organisms when challenged with
5.9 and 7.9 log (cfu) of Proteus mirabilis s-R9 challenge strain (Figure. 40).
B) Ten days treatment: (1 group of 8 mice)
Mice were treated for ten days with the SDD regimen, and challenged 
one day after treatment. Seven out eight mice were colonized for over two 
weeks after challenge when challenged with 7.5 log ( cfu) of Proteus mirabilis 
s-R9.
This results suggest that the period of colonisation resistance 
impairment after cessation of treatment may be proportional to the length of 
treatment (Figure. 40).
3.3.3.2.2 Challenge seven days after treatment: (3 groups of 8 mice)
Mice were treated for 5 or 10 days with SDD regimen, and challenged
seven days after the end of treatment.
A) Five days treatment: (2 groups of 8 mice)
Mice were challenged 7 days after the end of 5 days treatment SDD 
regimen. Five out eight mice lost the challenge organisms in less than two 
weeks challenged with 6.2 log (cfu) of Proteus mirabilis s-R9, but when 
challenged with 8.2 log (cfu) 6 out of 8 mice were colonized for two weeks after 
challenge (Figure. 41). This result is similar to that for challenge during 
treatment (section 3.3.3.1),
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Figure 40 Excretion of Proteus m irabilis  s-R9 challenge strain by 3 g roups
of 8 m ice challenged one day after the end of 5 and 10 days
treatm ent with PTA regimen.
mi
ce
 
ex
cre
tin
g 
the
 
ch
all
en
ge
 
or
ga
nis
m
s 
(%
)
144
_ _ a ------------- A -------------- A100
80
60
40
0 2 4 6 8 10 12 14
days after challenge
challenge dose log (cfu)
5 days SDD 5 days SDD 10 days SDD
. . t f .
7,5
-■■6-
Figure 41 Excretion of Proteus m irabilis  s-R9 challenge strain by 3 groups
of 8 m ice challenged 7 days after the end of 5 and 10 days
treatm ent with PTA regimen.
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B) Ten days treatment: (1 group of 8 mice)
Mice were treated for ten days with the SDD regimen, and challenged 
seven days after treatment. Six out of eight mice were colonized for two weeks 
after challenge when challenged with 7.5 log (cfu) of Proteus mirabilis s-R9 
(Figure. 41).
3.3.3.3 Challenged mice one day before treatment: ( 2 groups of 8
mice)
Mice were challenged with 9.3 and 10 log (cfu) of Proteus mirabilis s-R9 
challenge strain respectively. One day after challenge they started treatment 
with the SDD regimen for ten days. Thirteen out sixteen mice remained 
colonized for two weeks, whereas in control mice no colonisation occurred 
(Figure. 42).
3.3.4 Mice treated with cefotaxime: (4 groups of 8 mice)
Mice were treated for four days with 3 mg per day of cefotaxime given by 
i.p. injection. As the challenge organism was sensitive to CTX, one day after the 
end of treatment mice were challenged by gavage with 6, 8, 8.6, and 9.17 log 
(cfu) of Proteus mirabilis s-R9 challenge strain respectively. Twenty two out 
twenty four mice lost the challenge organisms in less than two weeks (Figure. 
43).
The colonisation resistance for mice treated with cefotaxime is higher 
than 9 log (cfu), and it appears to be similar to the colonisation resistance for 
control mice (Figure. 28).
3.3.5 Mice treated with SDD regimen with addition of systemic 
cefotaxime: (4 groups of 8 mice)
Mice were divided into 2 categories depending on the length of treatment 
with the SDD regimen.
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Figure 42 Excretion o f proteus m irabilis  s-R9 challenge strain by 2 groups
of 8 m ice challenged one day before trea tm ent for 10 days with
PTA regimen.
mi
ce
 
ex
cr
et
ing
 
the
 
ch
all
en
ge
 
or
ga
nis
m
s 
(%
)
147
100
60
40
days after challenge
challenge dose log (cfu)
Figure 43 Excretion o f proteus m irabilis  s-R9 challenge strain by 4 groups
of 8 m ice challenged one day after cessation o f treatm ent with
cefotaxime.
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Figure 44 Excretion of Proteus mirabilis s-R9 challenge strain by 5 group of 
8 mice treated with PTA regimen for 4 or 14 days, with addition of 
systemic cfotaxime for 4 days, challenged one day after cessation 
of cefotaxime, during PTA regimen.
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3.3.5.1 Four days treatment with SDD regimen: (2 groups of 8 mice)
Mice were treated for four days with the SDD regimen given by gavage, 
and 3 mg of cefotaxime given by i.p. injection. One day after treatment the mice 
were challenged by gavage with 6 and 8 log (cfu) of Proteus mirabilis s-R9 
challenge strain. Seven out eight mice were colonized for two weeks after 
challenge (Figure. 44).
3.3.5.2 Two weeks treatment with SDD regimen: (3 groups of 8 mice)
Mice were treated with for two weeks with the SDD regimen given by
gavage, and four days with 3 mg per day of systemic cefotaxime. Three groups 
of mice were challenged with 4.4,6.4, and 8.4 log (cfu) of proteus mirabilis s-R9 
challenge strain respectively. All mice were colonized for two weeks after 
challenge (Figure. 44).
The SDD regimen with the addition of systemic cefotaxime, affected the 
anaerobic flora (section 3.2.3.S), and impaired colonisation resistance, almost 
to the same level of colonisation resistance for mice treated with TDD regimen 
(section 3.3.2.1).
3.3.6 Mice treated with clindamycin: (2 groups of 8 mice)
Mice were treated for four days with 0.6 mg per day with clindamycin 
given by gavage. One day after treatment mice were challenged with 6.3 and 8.3 
log (cfu) of Proteus mirabilis s-R9 challenge strain. All mice were colonized for 
two weeks (Figure. 45).
Clindamycin reduced the anaerobic flora to a non detectable level 
(section 3.2.3.7), and impaired colonisation resistance.
Summary of the values of CR is shown in Table 12 p.176.
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3.4 Antibiotic Activity In Murine Faeces:
The antibiotic activity in the murine faeces or in the caecal content was 
determined in mice treated with TDD regimen, SDD regimen, orCTX.
3.4.1 Mice treated with TDD regimen:
Two groups of 4 mice were treated for two weeks with Streptomycin and 
neomycin (TDD antibiotics) given by:
group I : gavage 10 mg mouse'1 each ofSm and Nm given twice a day 
group II : ad libitum in drinking water 5 mg ml'1 of each Sm and Nm.
In group I (gavage treated mice), faecal pellets were collected from four 
mice 4, 8,12,16, and 24 hours after the end of treatment. The highest antibiotic 
activity was seen 8 hours after the last dose ( this results is different from single 
dose in results section 3.1.3). 24 hours after treatment antibiotic activity was 
detected in only 2 /4  mice ( Figure. 46).
In group II, faecal pellets were collected at five different times during 24 
hours during treatment. The antibiotic activity was not observed to rise or fall 
consistently over the sampling period of 24 hours ( Figure. 47).
3.4.2 Mice treated with SDD antibiotics:
Four mice were treated for two days with SDD regimens given by 
gavage. Faecal pellets were collected 4, 8,12,20, and 24 hours on the second 
day of treatment. Samples were prepared and assayed as described in 
(materials and methods 2.11.2). Zones of inhibition were seen only 4, 8, and 
20 hours after treatment, and no inhibition was seen at 12 and 24 hours after 
treatment. The highest antimicrobial activity was observed 8 hours after 
treatment (Figure. 48).
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Figure 46 Antibiotic activity in thefaeces of four mice treated with TDD 
antibiotics given by gavage 24 hours after end of treatment.
* o f  indicator strain : E. coli NCTC No. 10418.
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Figure 47 Antibiotic activity in the faeces of four mice treated with TDD 
antibiotics ad libitum in drinking water during 24 hours of 
treatment.
*  of indicator strain: E. coli NCTC No. 10418.
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Figure 48 Faecal antibiotic activity in four mice given SDD antibiotics by 
gavage during 24 hours after treatment. Results shown + SE 
of the mean.
*  of indicator strain: E. coli NCTC No. 10418.
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3.4.3 Mice treated with cefotaxime:
3.4.3.1 Concentration of cefotaxime in mouse caecum:
Two groups of ten mice were given an i.p. injection of 3 mg of 
cefotaxime.
Group I : treated for 1 day.
Group II : treated for 4 days.
One mouse from each group was dissected 2,4, 6, 8,10,12,16,18, 20, 
and 24 hours after treatment, caecum contents were collected , prepared, and 
assayed as described in (materials and methods 2.5). In group I, zones of 
inhibition were seen only 2, 6, 8, 16, 18, and 20 hours after treatment. The 
highest concentration was 20 pg g'1 of caecum contents 10 hours after 
treatment (Figure. 49). No further inhibition was observed 24 hours after 
treatment.
In group II, where mice were treated for four days, zones of inhibition 
were seen only at 2 hours after treatment, where the concentration was 1 jL/g g 1 
of caecum content, and no zone of inhibition was seen at any other time.
The experiment was repeated (figures not shown), and only at 2 hours 
after treatment was a zone of inhibition seen in either group. The concentration
of cefotaxime in the cecum of mice given cefotaxime for one day, and for four
days were 8.2 and 1 f jg. g'1 of caecal content respectively.
3.4.3.2 In vitro effect of Cefotaxime in murine faecal pellets:
3.4.3.2.1 Aerobic organisms:
Faecal pellets were collected 4 and 8 hours after treatment from four 
mice treated for two days with 3 mg. of cefotaxime, and the pellets were assayed 
for antimicrobial activity against Proteus mirabilis s-R9, E.coli S-R21, and 
Pseudomonas aeruginosa S-R321.
No antimicrobial activity against any of the challenge strains was observed.
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Figure 49 Concentration of cefotaxim e in the caecum  content of m ouse
during 24 hours after end of trea tm ent w ith cefotaxime.
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3.4.3.2.2 Anaerobic organisms:
The Cefotaxime in faeces did not have any visible effect on the 
anaerobic flora in vitro, as measured by inhibition of normal flora of murine 
faeces cultured on anaerobic blood agar plates and by direct microscopy of 
faeces. By contrast, an antibiotic disc containing 60 ^ g of cefotaxime inhibited 
the cultured anaerobic faecal flora in vitro (result not shown).
3.4.3.2.3 Concentration of cefotaxime which effects the anaerobic 
mormal flora:
Serial twofold dilutions of 3 mg ml'1 of cefotaxime were made and 
assayed for activity against murine faecal anaerobes. The lowest concentration 
of cefotaxime to show activity was 0.5 jig  ml'1. At this concentration the effect of 
cefotaxime was not seen on all types of colonies of anaerobic flora growing on 
anaerobic BA from murine faeces, whereas at higher concentrations all types 
ofthe anaerobic flora were affected (results notshown).
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Chapter Four
DISCUSSION
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4. Discussion:
4.1. Preliminary Experiments
The main stimulus for this study was the rapidly increasing use of SDD 
in ITU patients following the impressive results described for this technique in 
the prevention of ITU-aquired infection (Stoutenbeek et al., 1987; Ledingham 
et al., 1988; Konrad etal., 1989). The concept of CR is central to the use of 
SDD. However, CR remains a highly contentious hypothesis: the existence of 
the phenomenon has been denied (Sanderson, 1989; Nau et al., 1990), and 
when detected it has been variously ascribed to physical factors (Gordon and 
Pesti, 1971), to aerobic gut flora (Freter and Abrams, 1972; Ducluzeau et al., 
1977; Goren et al., 1984)), to anaerobic gut flora (van der Waaij et al., 1971; 
Wells, 1988) or to various combinations of these factors ( Hentges et al., 1985; 
Wells, 1988). Further, the experimental work in animals that forms the basis of 
the concept is dependent to a surprising degree on a restricted series of 
studies carried out by van der Waaij and co-workers between 1971 -1974 (van 
der Waaij etal., 1971; 1972; 1974; Wensinck and Ruseler-van Embden, 1971).
I therefore determined first to confirm the presence ofCR as described 
by van der Waaij in mice treated with TDD (van der Waaij et al., 1971). The 
same mouse model could be then used to study the widely employed SDD 
regimen first described by Stoutenbeek etal., (1984).
The first part of the thesis is essentially an attempt to repeat the 
experiments described by van der Waaij et al., in (1971). His procedures were 
followed as far as possible, but some changes were made. Using E.coli and 
enterococci as indicator organisms for aerobic faecal flora we were able to 
maintain TDD mice free of these bacteria for four weeks after cessation of 
treatment with TDD antibiotics. This was achieved by housing the mice 
individually in autoclaved cage in a normal room (see materiais and 
methods section 2.1.2) without the need for transferring the autoclaved cages
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to the peracetic acid-sterilized laminar cross-flow benches used by van der 
Waaij.
Van der Waaij used Swiss ND2 mice challenged with E.coli, Klebsiella 
pneumoniae and Pseudomonas aeruginosa (van der Waaij etal., 1971). These 
mouse-derived strains were resistant to streptomycin and to neomycin, the 
TDD agents used. We used Balb/c mice because our animal laboratory did not 
breed Swiss ND2 mice. Also, the diversity of mice used in previous 
experiments in this field; NIH, OT, Balb / c and C3H mice (Speekenbrinketal., 
1987,1988), C57BL/ Rij, CBA/ Rij, C3H, ROF, and ND22 strains (van der Waaij 
and Strum, 1968), and Swiss Cpb: SE mice (Koopman et al., 1981) suggested 
that the particular strain of mouse would not significantly affect the results 
obtained.
In order to obtain suitable mouse-derived strains of challenge 
organisms, we used a range of selective media for isolation of different aerobic 
gram negative bacteria and Candida albicans from mouse faecal pellets and 
from different parts of the gut (materials and methods section 2.3 and 2.6.3), 
Despite considerable efforts, it proved impossible to isolate mouse-derived 
strains of Pseudomonas aeruginosa or Klebsiella pneumoniae. This suggests 
that these experimental laboratory mice do not carry these organisms as part of 
their gut flora.
Preliminary experiments established that challenge organisms required 
to be resistant to at least 10 g I1 each of streptomycin and neomycin in order 
to resist the level of these drugs found in faeces during treatment. We 
attempted to enhance the resistance of promising mouse and human strains to 
the TDD antibiotics used. Again, considerable difficulties were experienced 
despite the use of a variety of procedures (materials and methods section
2.3 and 2.6.3).
161
To challenge mice during TDD and SDD treatment fully resistant 
challenge strains were required. We tested murine isolates of£.co//s-R21 and 
Proteus mirabilis s-R9, and human isolates of Klebsiella pneumoniae S-R10, 
Pseudomonas aeruginosa S-R321, Providencia stuartii s-R7 and Pseudomonas 
cepacia S-R13. Potentially resistant strains were selected by passage in BHIB 
containing increasing concentration of one of the TDD drugs (Sm, Nm)orSDD 
drugs (Tn, Pe).
Eventually, the challenge strains employed were:-
- E.coli s-R21: this is a moused-derived strain made resistant to 10 gl‘1 
streptomycin by multiple passage and made resistant to 10 gl'1 neomycin by 
transfer of plasmid RP4.
- Pseudomonas aeruginosa S-R321: this strain is of human origin made 
resistant to 10gl'1 each of streptomycin and neomycin by multiple passage in 
increasing concentrations of Sm and Nm.
Unfortunately, we were unable to repeat van der Waaij's experiment with 
Klebsiella pneumoniae in totally decontaminated mice. We failed to isolate this 
organism from mice and it proved impossible to make human-derived strains 
that were sufficiently resistant to the TDD antibiotics. Also, strains of this 
organisms failed to colonize totally decontaminated mice, even in the absence 
of the decontaminating drugs.
The problems encountered with the TDD challenge strains were even 
greater when we tried to find suitable challenge strains for the SDD studies. 
The original plan was to obtain multiple challenge strains to be used in both 
TDD and SDD experiments. Unfortunately, we were unable to make E.coli, 
Klebsiella pneumoniae and Pseudomonas aeruginosa resistant to the PTA 
drugs. We managed to obtain one challenge strain (Proteus mirabilis s-R9) 
resistant to 0.5 g r1 of tobramycin and resistant to > 1 g I'1 of polymyxin. This
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strain was resistant to both PTA and TDD drugs; however, it remained 
sensitive to cefotaxime.
Although in principle it may be possible to obtain many strains which 
have the required resistance pattern, the combined requirements of both the 
ability to colonize mice and resistance appear to be much less easy to 
achieve. The reason is probably that organisms with a high level of intrinsic 
resistance to antibiotics tend to be opportunistic pathogens e. g. 
Pseudomonas cepacia, but these organisms rarely successfully colonize 
uncompromised hosts. Endogenous organisms of the intestine, not 
intrinsically resistant to PTA or TDD antibiotics, would require independent 
mutation to resistance for each antibiotic.This is a highly improbable event and 
may also affect the organisms ability to colonize.
Passaging resistant organisms through the intended host may 
overcome the latter problem. This procedure was not attempted in this study. 
Additionally, plasmids bearing antibiotic resistance markers may be 
introduced into suitable endogenous organisms; although this approach is 
likely to require much effort, it may be a more certain and reproducible way of 
obtaining suitably resistant organisms without affecting their ability to colonize.
Van der Waaij gave no information on the stability of the antibiotics used 
in drinking water or about how often the drugs were changed. We found that 
the drinking water containing the TDD antibiotics given to mice during the 14 
days of treatment had to be changed every 5 days, as the combination of Sm 
and Nm in water was unstable after 6 days. The activity of the combination of 
Sm and Nm in water had decreased by 52 % after 6 days, and by testing the 
activity of Nm alone it was observed that its activity had decreased by 51 % 
after 6 days. This finding suggested that this instability of the TDD antibiotics in 
drinking water was due to the deterioration of Nm in water at room temperature.
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This may have implications for the interpretation of van der Waaij's data as it 
suggests that his mice were treated with reduced active concentration of drugs 
after about 5 days.
Having determined the experimental conditions, it was then necessary 
to determine the normal flora present in the intestine of the experimental mice. 
We chose to study the normal flora of the gut as present in faecal pellets which 
represent the large bowel flora, rather than using caecal contents which have 
been used in previous studies (Lee, 1971; Brown and Balish, 1978). This was 
done because van der Waaij et al., (1971) used faecal pellets in his study and 
because they are a convenient source of the large intestinal flora. Also, this 
sampling technique does not require the sacrifice of mice, a procedure that 
would have been impossible in the present study as we studied the flora in mice 
before, during and after treatment with TDD antibiotics.
The results of aerobic culture were consistently compatible with the 
microscopy findings. It was therefore assumed that the aerobic culture 
technique allowed an acceptably accurate estimate of at least the total viable 
bacterial count of the faecal pellets. Aerobic culture yielded 4 - 5 different colony 
types. There was overwhelming preponderance of E.coli (5.8 +_ 0.2 logcfu /g  
of faecal pellets) and enterococci (6.9 +_ 0.1 log cfu / g of faeces). These 
organisms were also assumed to reflect the changes seen as a result of 
antibiotic treatment on other aerobes that were either rarely present or usually 
present in very low numbers. However, the media used always included a non- 
selective medium and the culture conditions employed were not restrictive to 
certain types of organisms. In terms of the literature (Brown and Balish, 1978), 
we expected that the media and aerobic techniques used would grow all 
aerobic organisms present in the faecal samples.
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Technical considerations are accepted to impose major constraints on 
the study of anaerobic gut flora (Lee, 1971). Since 1960, however, the 
application of improved anaerobic technique, and improved media, has 
allowed bacteriologists to culture up to 85 % of the cells present, and make 
some progress in characterizing the flora (Moore and Holdeman, 1974). In this 
study we only investigated the total viable count of anaerobic flora. 
Subpopulations were then identified only on the basis of colonial morphology 
and gram morphology. We did not attempt to further characterize these 
organisms for the following reasons:
1) In the context of colonization resistance, we considered that the overall 
count of the anaerobic bacteria was probably more important than the 
distribution of individual species (van der Waaij etal., (1971).
2) A wide range of cultural conditions would be required to meet the in vitro 
growth requirements of different strains. The conditions needed to isolate 
subpopulations of the anaerobic flora have been found to be more stringent 
than those needed for a TVC. The reason for this are unclear but probably 
include satellitism and the provision of a reducing environment.
3) The great range of different kinds of bacteria which must be cultured, 
characterized, and catalogued in order to gain an understanding of there 
ecological role and interrelationships.
4) The technical complexity of such a studies and the difficulty in relating very 
complex patterns of species to changes in CR.
In these circumstances, the interpretative limitations associated with 
TVC data were regarded as acceptable, particularly as van der Waaij et al., 
(1971) described no anaerobic data of any description in their studies.
Caldwell and Bryant, (1966) reported that the medium M10 agar is 
highly effective for nonselective enumeration and isolation of rumen bacteria,
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and that it showed a higher TVC when compared to other media. However, in 
our hands anaerobic blood agar produced higher anaerobic TVC values than 
MIOagarfor faecal extracts and the colony types, shape and colorwere easier 
to distinguish. Anaerobic BA was therefore used throughout the study. In 
addition, we followed the methods for isolating fastidiously anaerobic bacteria 
i.e.- minimal exposure of faecal pellets or gut contents to air, inoculation onto 
pre-reduced media, and incubation under anoxic conditions as described by 
Drasar, (1967); Aranki et al., (1969); Moore et al., (1969); and Gordon and 
Dubos (1970).
The mean T.V.C. was 10.5 •+ 0.06 log (cfu /g ) of faecal pellets for control 
mice. This was almost identical to other published studies where the total 
cultivable flora of the mouse intestinal content was found to be 1010 -1011 cells / 
gram of intestinal content (Moore etal., 1969; Savage etal., 1971). Only 12+^1 
different colony types were seen which mainly consisted of spore-forming 
gram positive bacilli and fusiform bacteria. The large numbers of strains known 
to be present, presumably present in lower numbers, were not detected as 
selective media were not used (results section 3.2.3.1).
These anaerobic culture studies were supplemented by the assay of 6- 
aspgly in mouse faecal pellets, as an additional indicator of anaerobic flora 
(Welling, 1979; Emmelotand van der Waaij, 1980; Manson etal., 1981; van der 
Waaij et al., 1982). The identification of 6-aspgly in HPLC profiles depended 
upon the identification in experimental samples of a single discrete peak with 
the same retention characteristics as the peak obtained with 6-aspgly control 
assayed in parallel. The indicator used, O-phthaldialdehyde, only labels amino 
acids and short peptides, and a study of standard amino acids revealed none 
with a retention time similar to that seen with the B-aspgly standard (result not 
shown). However, no appropriate internal standard for 6-aspgly was available 
in the system we used (material and methods section 2.12).
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In faeces from control mice, no peak with a retention time similar to that 
ofB-aspgly was detected. By contrast, such a peak was consistently present in 
mice treated with TDD antibiotics and showed to have a marked reduction in 
the levels of faecal anaerobes. These results agree with the behavior of B- 
aspgly as detected by paper chromatography by Welling et al., (1978) and as 
described by others (Welling and Groen, 1978; Welling, 1979; Emmelot and 
van der Waaij, 1980; Manson et al., 1981; van der Waaij et al., 1982). However, 
some caution in their interpretation is required. Entirely contradictory results 
were obtained in one isolated experiment involving clindamycin when no 0- 
aspgly were detected following the apparent elimination of the anaerobic 
flora (result not shown). However, this was probably due to inappropriate 
storage of the faecal samples before B-aspgly assay. Overall I think that this 
technique provided useful auxiliary data when considering the effects of 
decontamination regimens on faecal anaerobic flora.
The choice of Balb /  c mice can be criticized in that they represent a 
markedly abnormal model. The animals are inbred laboratory strains raised in 
a grossly abnormal environment designed to minimize problems of infection 
and subjected to a carefully standardized, sterilized diet. Their normal faecal 
flora (and response to microbial challenge) may differ markedly from wild mice 
as has been commented by other workers. Limited studies were therefore 
carried out with wild mice in an attempt to clarify this problem ( and as a 
possible source of challenge strains).
The aerobic normal flora of wild mice was found to be simpler than that 
obtained from Balb / c control mice: the wild mouse aerobic flora consisted 
only of 2 different strains of E.coli, and no other organism was seen. As the 
intestinal flora of the laboratory mouse is generally described as simplified, this 
result is surprising. This variation in the normal flora between the 2 strains of 
mice could be due to many factors including the environment and diet (Aries et
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al., 1969). There is a paucity of references concerning effects of diet on aerobic 
flora, however, numerous studies with anaerobic flora have shown that diet may 
have material effects. For example Americans have lower counts of Clostridia in 
their faeces than people living in Japan (Akama and Otani, 1970). Ueno and 
colleagues (Ueno etal., 1974) also pointed out certain differences with regard 
to gram negative anaerobic bacilli in people on traditional Japanese diet, and 
those on a western diet. Aries et al. (1969) noted significantly more Bacteroides 
and Bifidobacterium species in faecal specimens from English subjects than in 
specimens from Ugandans. However, within these populations, the intestinal 
bacterial populations are remarkably stable.
In contrast there was little difference in the anaerobic normal flora of 
Balb / c and wild mice by the criteria employed. Although the TVC in wild mice 
was lower by 1 log (cfu), the gram and cultural morphology was almost 
identical to that of control mice.
It is of interest to note that we failed to isolate a mouse-derived Ps. 
aeruginosa and Kl. pneumoniae from the 3 wild mice for use in challenge 
experiments. The wild mice were delicate and difficult to handle making them 
unsuitable for challenge experiments even if this had been legal.
4.2. Studies With Control Mice:
Van der Waaij's method for quantification of colonization resistance was 
employed throughout this study (van der Waaij et al., 1971). Colonization 
resistance was expressed as the log  ^of the minimum oral (gavage) dose of an 
organism that was associated with isolation of the challenge strain from at 
least 50 % of treated mice for a period of at least two weeks. This approach 
generated both a numerical assessment of the strength of CR and auxiliary data 
concerning the pattern of excretion ofthe challenge strain.
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The results of this study confirmed van der Waaij's finding of a very high 
CR in untreated control mice. However, there were significant differences of 
detail between the two studies.
The failure to colonize conventional control mice for two weeks when 
given 9-10 log (cfu) of Klebsiella pneumoniae or Pseudomonas aeruginosa 
challenge strains (results section. Table. 11), supports the finding of van der 
Waaij. However, there is a variation in the values of CR for E.coli challenge 
strains between the two studies. In the present study the value of CR for E.coli 
s-R21 challenge strain was 8 whereas van der Waaij reported that the CR for 
his E.coli challenge strain in control mice was 7.
Another variation between the two studies isthe clearance of the 
challenge strain after challenge. Van der Waaij only recorded the presence or 
absence of the challenge strain in the faeces after challenge. We additionally 
followed the total viable count of the challenge organism over the experimental 
period. The mean TVC of E.coli S-R21 challenge strain in the colonized mice 
varied between 106 and 10a cfu / gram of faeces during the 14 days after 
challenge. ( Van der Waaij presented no data of any kind in this area). This 
pattern was not seen when mice were challenged with doses between 5 log - 7 
log (cfu), where the£.co//'s-R21 could no longer be detected 3 -5days after 
challenge. In these circumstances, the clearance of E.coli challenge strain in 
van der Waaij's study was slower: between 30 % - 40% of mice were colonized 
fortwo weeks when challenged with 5 log (cfu).
The CR for Klebsiella pneumoniae and Pseudomonas aeruginosa in 
control mice were similar in the two studies, but there was a difference in the 
clearance rate of these challenge strains. In van der Waaij's study, between 
10% - 20% of the challenged mice were still colonized two weeks after 
challenge when challenged with 9 log (cfu). However, in the present study the
169
7 challenge strains disappeared completely when given at high challenge 
doses between 8.5 log -10 log (cfu) between day 1 - 7 after challenge ( the 
clearance of the challenge organisms from the faeces was proportional to the 
challenge dose). The faecal clearance also varied both between challenge 
strains, and between different mice subjected almost to the same challenge. 
For example, control mice reproducibly lost all the Proteus mirabilis s-R9 
challenge strain in 7 days after challenge with 9 log (cfu), whereas a complete 
clearance of Providencia stuartii s-R7 challenge strain from all of the 
challenged mice occurred one day after challenge with the same dose.
These variations between the two studies could be due to numerous 
factors, the use of different mouse strains housed under different conditions, 
the different diet given to the mice, the use of different challenge strains, and 
inevitable minor differences in technique. Nevertheless, the studies with control 
mice broadly supported van der Waaij's finding of a very high CR that is 
materially affected by the genus and species species of the challenge challenge 
strain employed.
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4.3 Studies With Totally Decontaminated Mice:
In these studies van der Waaij and colleagues published only limited 
data concerning the aerobic and the anaerobic faecal flora before, during and 
after treatment. They unequivocally reported that all mice which were treated 
with TDD antibiotics became free of all of the aerobic flora, but no data of the 
anaerobic flora were given (van der Waaij et al., 1971; 1972; van der Waaij and 
Berghuis-de vries, 1974).
In contrast, fairly extensive monitoring was undertaken in the present 
study. TDD antibiotics were associated with a reduction in all of the aerobic 
flora to a non detectable level only one day after starting treatment. This flora 
did not recover during the two weeks of the treatment period, and recovery 
after stopping treatment was very slow when mice were kept in clean 
environment (Materials and methods section 2.1.2) to avoid the risk of 
contamination. In seventy percent of mice enterococci reappeared by day 5- 
7 after stopping treatment, but E.coli had not reappeared 3 - 4 weeks after 
stopping treatment. These faecal findings were extended by the study of the 
microbial flora in 5 parts of the mouse gut; upper jejunum, lower jejunum, ileum 
, caecum, and colon (a single experiment). These sites all yielded enterococci 
and E.coli before TDD, but these organisms were not isolated during TDD. In 
contrast to the previous studies enterococci were also absent both from these 
sites and from faeces for 4 weeks after stopping TDD treatment. These results 
illustrate the difficulties of obtaining reproducible results from experiment to 
experiment, but support the use of faeces as an index of mouse intestinal 
aerobic flora.
Although the TDD antibiotics were clearly very active against faecal 
aerobes, the effect on the anaerobic flora was less marked. Seventy percent of 
treated mice, whilst showing a reduction and simplification of anaerobic flora,
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still showed appreciable anaerobic flora during TDD ( results section 
3.2.3.3). Gram films of these organisms showed gram positive rods with 
terminal spores, and gram positive fat rods. I think that these organisms may 
have been ofthe genus Clostridium.. In the present study we will refer to these 
organisms as" anaerobic gram positive spore bearer" (ANGPS).
As I mentioned earlier, in this study we did not characterize and study 
the TVC of each individual organism of the normal anaerobic flora before, 
during or after treatment. However, we did estimate the TVC ofthe ANGPS 
because of their resistance to van der Waaij's TDD regimen. During treatment, 
they were present at a concentration of 9 + 0 . 2  log (cfu / gram of faeces), and 
this decreased to 6.9 +_ 1.4 log( cfu /gram) offaeces2-3days after treatment 
(which is similar to the normal level of Clostridium spp. in conventional mice). 
This decrease in the TVC of ANGPS after stopping treatment might be due to 
the recovery of other anaerobic species and some of the aerobic flora. 
However, overall recovery of the anaerobes took much longer than the 
changes in ANGPS.
More generally, only a fraction of the anaerobic flora was recovered 
after treatment. The mean total viable count was 10.35 ■+ 0.2 log (cfu / gram of 
faeces) 7 days after stopping treatment and this result was maintained at 14 
days after stopping treatment. In contrast, only 4^-1 types of different colonies 
were seen 7 days after stopping treatment and only 6 +_ 1 colony types were 
seen 14 days after stopping treatment compared to 12+^1 types of colonies 
for control mice. Wensinck and Ruseler-van Embden (1971) described studies 
of the caecal flora of the offspring of germ-free mice contaminated with the 
anaerobes ofCRF-mice which were originally obtained from one mouse two 
weeks after stopping antibiotics: only five species were present, and the major 
constituents were tapered rods belonging to the genus Clostridium. This 
supports the pattern of results obtained in the present study. Slow recovery of
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simplified anaerobic flora after stopping TDD treatment is also described by 
van der Waaij et al., (1971) who stated that anaerobes in mouse faeces 
obtained 14 days after stopping treatment represented the fraction of 
conventional intestinal flora which survived treatment with TDD antibiotics. 
However, van der Waaij did not include in his work a study of the anaerobic 
flora before, during, and immediately after treatment in order to compare 
directly these data with the flora of mice two weeks after stopping treatment.
The 6-aspgly findings also suggests an impairment of the anaerobic 
flora with TDD antibiotics. As expected 6-aspgly was not seen in the faeces of 
control untreated mice. However, the concentration of 6-aspgly increased 
sharply in mouse faeces during treatment with TDD antibiotics. After stopping 
TDD, a variable decrease, but not a sharp fall in the concentration of 6-aspgly 
was seen. This variation in the concentration of 6-aspgly between different 
mice matched the rate of recovery of the anaerobic normal flora in each 
individual mouse as revealed by bacteriological studies. These results 
therefore support the slow recovery of anaerobic flora described earlier and the 
utility of 6-aspgly as an auxiliary index of intestinal anaerobic flora.
In summary, my findings suggest that the TDD antibiotics used by van 
der Waaij et al. (1971) are very active against the aerobic flora but only 
partially active against gut anaerobic flora. In other words, van der Waaij's TDD 
regimen was only partially effective. Van der Waaij's comments in this area are 
contradictory, on the one hand he implied that TDD was established during 
treatment (van der Waaij et al., 1971) and on the other he reported in his 
conclusion that reconstitution of CR was due to those anaerobic organisms 
which survived the antibiotics and subsequently repopulated the intestinal 
tract.
During treatment with TDD antibiotics a marked impairment ofCRwas
173
observed. Two days after the onset of oral administration of TDD antibiotics 
the value of CR for E.coli S-R21 challenge strain decreased to < 2, and 
remained at this level during the 14 days of treatment. This value of CR is very 
low compared to conventional control mice where the CR was approximately 
8. This means that totally decontaminated mice can easily be colonized with a 
very low dose (40 cells) of E.coli S-R21 challenge strain during treatment. 
These results agree with van der Waaij's group, who also reported that the CR 
for E.coli during treatment with TDD antibiotics was < 2 (van der Waaij et al., 
1971).
Bohnhoff and Miller (1962) described a similar difference in response 
between conventional mice, and streptomycin treated mice. In this study the 
untreated mice required approximately 6 log (cfu) of Salmonella enteritidis 
cells by stomach tube to colonize the gut of 50 % of mice. With lower doses 
fewer mice, and with higher doses (between 6 log cfu - 9 log (cfu)) more mice 
became colonized. In contrast, in streptomycin treated mice, doses as low as 
10 cells or less colonized 50% of mice. Dubosetal., (1963), and Savage and 
Dubos, (1968) also reported abnormal colonization with E.coli and evidence 
of overgrowth during the entire period of suppression ofthe anaerobic flora 
responsible for CR by oral treatment with penicillin or oxytetracycline, even 
though TDD was not fully established. Unfortunately, none of these studies 
provided detailed information on the bacteriological status of the experimental 
mice.
During TDD treatment, the challenge organism, E.co//s-R21, multiplied 
extensively and persisted in the gut of the mice, and the TVC increased to 
almost 9 log cfu / gram of faeces (results Fig. 34). This level was almost the 
same in all the colonized mice, and exceeded the concentration of E.coli seen 
in control mice.
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The level dropped by 2 - 3 logs during the 14 days after stopping 
treatment. This fall in numbers varied between the different groups of mice in 
the range of 6.5 - 8 log (cfu), but in general the TVC for E.coli in control and TDD 
mice was similar 14 days after stopping treatment. At this time the anaerobic 
TVC was 10.35 + 0.2 log (cfu / gram of faeces) with 6 -M  colony types, and 
enterococci were also seen. Similar results were seen in mice treated with 
streptomycin (Bohnhoff & Miller, 1962): the TVC of Salmonella enteritidls 
challenge strain was 6 log (cfu / single pellet of faeces) during treatment, where 
as in control untreated mice the TVC was 4 log (cfu/single pellet of faeces).
These findings suggest that the fall in the TVC of the challenge 
organism in decontaminated mice after stopping treatment may have been 
due to the partial recovery of the normal flora. Schaedler et al. (1965) 
reported that after oral challenge of germ-free mice the coliform bacilli 
multiplied extensively and persisted in all parts of the gastrointestinal tract. 
Their numbers then fell precipitously when the mice were fed the intestinal 
contents of healthy pathogen-free mice. Taken together these data clearly 
demonstrate the important role of the resident intestinal flora in host 
resistance to orally introduced organisms.
During treatment with TDD antibiotics 70 % of mice were not totally 
decontaminated due to the presence of ANGPS. However, the CR for E.coli 
s-R21 of completely and partially decontaminated mice was the same. 
Therefore, partial retention of the anaerobic flora (ANGPS) did not have any 
observed effect on the colonization by E.coli S-R21. Although van der Waaij et 
al., (1971) implied that TDD was complete, the flora reconstitution data 
indicated survival of at least some anaerobic flora.
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Van der Waaij et al., (1971) reported that during treatment theCR for all 
of the 3 challenge organisms they tested (E.coli, Kl. pneumoniae, and Ps. 
aeruginosa) was < 2. In contrast, the present study revealed a marked 
variation in CR with different challenge organisms: during treatment with fully 
established TDD the CR for Ps. aeruginosa S-R321 was approximately 8 
(Table. 12). Thus the CR for Ps. aeruginosa S-R321 in TDD mice was almost 
identical to that of E.coii S-R21 in control mice. However, the CR for Ps. 
aeruginosa S-R321 was still reduced by TDD - because control mice were not 
colonized by a challenge of 10log(cfu) o1 Ps. aeruginosa s-R32*\.
When TDD partially failed due to the presence of ANGPS theCR was 
higher (6 /8  mice lost the challenge organisms when challenged with a dose 
of 7.7 log (cfu) of Ps. aeruginosa S-R321 by day 7 after challenge). The loss of 
this challenge organism from mice with residual anaerobic flora was thus 
faster than from totally decontaminated mice. In contrast, partial retention of 
anaerobic flora did not have any observed effect on colonization by E.coli 
S-R21 in mice during treatment.
This variation between the two studies in the value of CR for Ps. 
aeruginosa challenge strain during treatment might be due to the origin of 
the challenge strain. Van der Waaij used a mouse-derived strain, whereas our 
challenge strain was of human origin and thus might not have the same 
ability to colonize mouse gut. It also might be due to the presence of the 
residual anaerobic flora (ANGPS) during challenge. However, when TDD was 
fully established mice were not colonized when challenged with 3.7 log (cfu) 
of Ps. aeruginosa S-R321 which is still greater the value of 2 log (cfu) reported 
by van der Waaij.
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T ab le  12 Summary of CR and anaerobic flora in different groups 
of 8 mice.
Treatment Challenge
strain
CR* Diversity of anaerobic flora
Control E.coli
Ps. aeruginosa 
Pr. mirabilis
8.2 
> 10a 
> 10“
12-16 colony types at 10'6
TDD antibiotics E.coli
Ps. aeruginosa
1.6
8
occasional ANGPS 1 - 2 colony 
types
PTA Pr. mirabilis 8 not affected significantly
Cefotaxime0 Pr. mirabilis >9 .2 “ Simplification occurred, 
reduction from 12-16 colony 
types to only 2 - 4 colony types
PTA + cefotaxime0 Pr. mirabilis <4.4° Simplification occurred, 
reduction from 12-16 colony 
types to only 1 -2 colony types
*  Log of oral dose which resulted in colonisation of 50% of mice for at least 14 
days.
a. Colonization criteria were not met by the highest dose employed, in this case 
106 cfu.
b. Assayed 1 day after stopping treatment.
c. The lowest challenge employed.
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Immediately after stopping treatment van der Waaij et al., (1971), found 
that the CR for E. coli was very low (< 2) . Fourteen days after stopping 
treatment the CR had recovered to 9 which was the same or higher than the 
CRfor control, untreated mice. As elsewhere, essentially similar results were 
obtained for Klebsiella pneumoniae and Pseudomonas aeruginosa at this 
time.
There was a minimum of detailed bacteriological data throughout his 
study. However, he stated that the recovery in the CR during the 14 days 
after stopping treatment, was coincident with profound changes in the 
intestinal flora, although he did not show any data for the recovery of the 
normal flora (van der Waaij et. al., 1971). These experiments were then 
extended by studies of reconstitution of germ-free mice (van der Waaij et. al., 
1971). It is not clear from the text whether the original reconstituted germ-free 
mice, the offspring of those reconstituted mice, or both were used for further 
challenge studies, therefore, the data in this particular study are difficult to 
interpret and this is a major weakness of this study. They stated that flora from 
mouse faeces taken two weeks after stopping TDD treatment (consisting of 
anaerobes only), were given to germ-free mice. The flora of offspring (CRF- 
mice) of these reconstituted germ-free mice consisted of only 5 different 
species mainly of the genus Clostridium (Wensinck et. al., 1971), presumably 
the same as those of the reconstituted parents. They reported that the pattern 
of elimination of the challenge E.coli by CRF-mice (which have a simplified gut 
flora) closely resembled elimination by mice two weeks after stopping TDD 
treatment, and the CR was about 9, which is similar to that of conventional 
control mice. The author did not state the CR for germ free mice, but it was 
implied thatthis grossly reduced. It is unfortunate that this important study did
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not contain more explicit information in this area; this experiment ought to be 
repeated.
From these studies van der Waaij concluded that the recovery in CR 
after impairment by TDD was due to the anaerobic subpopulations surviving 
TDD that gradually repopulated the intestine after stopping treatment.
In the present study theCR for E.coli S-R21 immediately after stopping 
treatment with TDD antibiotics was also < 2 (approximately 1.3) and the CR for 
E.coli s-R21 two weeks after stopping treatment had increased to 4. 
However, as described, the recovery of the normal flora was slow and not fully 
complete during the period of 14 days after stopping treatment when only 6+^ 
1 types of colonies were recovered. Thus partial recovery of normal flora after 
stopping treatment was matched by a partial recovery of CR for E.coli.
As explained, I was unable to colonize either control or totally 
decontaminated mice with Klebsiella pneumoniae and Pseudomonas 
aeruginosa during TDD treatment. There are therefore no results involving 
these organismsrelated to post TDD period.
The CR results obtained with E.CO//S-R21 totally disagree with van der 
Waaij et. al., (1971) and their observation thatCR had returned to normal 
values at 14 days. This discrepancy is the more striking in that both the 
"normalized" mice described by van der Waaij, et. al., (1971) and the mice 
used in our experiments were colonized with a simplified anaerobic flora 
consisting of 6+^1 colony types. Koopman etal., (1981) also disagreed with 
the contention that CR can be restored with a simplified anaerobic mouse 
flora of 5 strains. They suggested that a very complex gastrointestinal 
microflora was needed to normalize germ-free mice. Other studies including 
those conducted by Sayed et al., (1970), and Freter and Abrams (1972) also
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disagreed, in that they were only able to normalize the CR of germ-free mice 
with mixed population of morethanlOO bacterial strains. These data, including 
our findings, suggests that the normalization of CR can only be obtained with a 
complex microflora, and it appears that complete normalization with relatively 
simple flora is unlikely to be successful.
As a footnote to these studies we demonstrated that the mode of 
administration of decontaminating drugs had a major effect on the result 
obtained. When mice were treated by gavage with TDD antibiotics 3 /8  mice 
lost the challenge organism E.coli S-R21 during treatment. This was ascribed 
to a peak of faecal antibiotic activity observed 8 hours after the last dose of 
antibiotics (result Fig. 46), whereas in mice treated ad libitum in drinking water 
all mice were colonized for 2 weeks (result Fig. 4) and the faecal antibiotic 
activity was almost stable over the sampling period of 24 hours (result Fig. 
47).
In summary, our studies with TDD and control mice support the 
concept of CR, confirm that it can be reproducibly quantified, confirm that it can 
be markedly reduced by TDD regimens, and that the recovery of CR after 
termination of TDD antibiotics is associated with recovery of faecal flora. 
However, it is clear that these phenomenon reflect more complex mechanisms 
than those described by van der Waaij et al., (1971) and, also, that experimental 
detail may have a major influence on the outcome of results.
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4.4. Effect Of SDD Regimen On Intestinal Normal Flora:
The mouse model used for the TDD studies was employed to study the 
PTA (polymyxin, tobramycin, and amphotericin B) SDD regimen described by 
Stoutenbeek et al., (1984) and subsequently widely employed in clinical 
practice. There have been very few previous studies of the effects of PTA on 
mouse faecal flora (Speekenbrink etal., 1987) and none concerning the effect 
on CR as measured by oral challenge of experimental animals.
It was unfortunate that we had to use a different challenge strain 
(Proteus mirabilis s-R9 resistant to SDD antibiotics) from that employed in the 
TDD studies, as it is well recognized this complicates the comparison of the 
TDD and SDD data. However, despite the extensive and detailed studies 
described in (material and methods section. 2.6.3) it proved impossible to 
obtain a challenge strain with the requisite pattern of antibiotic resistance. 
This whole area proved to be much more difficult than expected, and 
deserves major attention for future studies.
The PTA regimen proved to have a highly selective action on faecal 
flora and this selectivity extended to different species of aerobic bacteria. 
E.coli was reduced to a non detectable level after one dose of treatment and 
had not recovered two weeks after cessation of treatment (results section. 
3.2.2A). By contrast, no significant changes were seen in the TVC of 
enterococci during or after treatment. This elimination of E.coli and 
maintenance of enterococci was also reported by Speekenbrink etal., (1987) 
when they used the PTA regimen described byStoutenbeek etal., (1984).
Recovery of the eliminated aerobic flora was not seen within 10 days 
after stopping PTA. Recovery was seen by Speekenbrink et al., (1987), but 
they housed treated with untreated mice, a procedure not employed in the 
present study. Recovery of Enterobacteria in mice after stopping treatment 
was also seen in study by Rogers et. al., (1985) when co-housed with
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untreated mice.
In previous studies of PTA in patients by deVries-Hospersetal., (1981) 
and Sleigfer etal., (1983) have shown the same pattern of effective removal of 
AGNB whilst retaining pre-existing population levels of enterococci.
In previous investigations using polymyxin or tobramycin as a single 
drug, a similarly rapid effect on AGNB was reported compared to other drugs 
used. DeVries-Hospersetal., (1981), noted that the faecal culture became free 
of AGNB one week after the start of nalidixic acid or co-trimoxazole, but with 
polymyxin this was achieved within a few days. Van der Waaij et al., (1982) 
reported that tobramycin was very effective against the endogenous 
Enterobacteriaceae, and it's effects on enterococci was relatively small 
compared to other drugs.
The effect of PTA antibiotics on the anaerobic flora was very limited. A 
very small increase by (0.66 +_ 0.2 log cfu) in the TVC of anaerobic flora was 
seen during treatment, and this returned to normal level one day after 
cessation of treatment. However, gram films indicated a simplification in the 
anaerobic flora. This was associated with a reduction in colony types of 
anaerobic gram negative rods (results Fig. 5 and 6). An increase in the 
concentration of 8-aspgly (results Fig. 23) was also seen in these 
circumstances. This can not readily be explained in terms of TVC, and it has 
never previously been suggested that simplification o f anaerobic flora is 
associated with elevated B-aspgly levels. However, Welling et al., (1988) 
reported that a number of different strains of anaerobic bacteria may produce 
the enzyme B-aspartylpeptidases.
Taken together, these results suggests that the PTA antibiotics did 
affect the composition of anaerobic parts of the intestinal flora, even though 
the anaerobic TVC remained unchanged. There have been no previous
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studies of the effect of the of PTA regimen on anaerobic faecal flora in mice. 
However, the activity of polymyxin or tobramycin as a single drug on the 
intestinal flora has been extensively studied in both man (Guiot and Janssen, 
1975; de Gast and van Saene, 1979; de Vries-Hospers et al., 1981) and mice 
(Emmelot and van der Waaij, 1980; van der Waaij et al., 1982). No direct 
bacteriological data of the effect of these drugs on the anaerobic flora have 
been reported, but indirect studies involving measurement of CR and B-aspgly 
were interpreted in terms of a reduction in anaerobic flora. Van der Waaij et 
al., (1982), reported that during treatment of mice with oral tobramycin at 
doses between 0.9 - 2.9 mg mouse'1 daily, the CR was not affected according 
to the parameters used. However, higher doses of tobramycin did decrease the 
CR. Mulder et al., (1984) reported a similar decrease in the CR in human 
studies. By contrast, changes in CR have not been recorded following 
treatment with polymyxin (van der Waaij etal., 1982).
Treatment with cefotaxime alone also had a highly selective effect on 
mouse faecal flora. E.coli was reduced to a non detectable level after one i.p. 
dose and had not recovered two weeks after stopping treatment. However, 
this effect was associated with a significant increase in the TVC of enterococci 
(by 1.1 0.6 log (cfu)), which returned to normal levekwithin 3 days after
stopping treatment.
Treatment with CTX alone also showed a significant effect on the 
anaerobic flora. Although there was no significant difference in the total 
anaerobic TVC, there was a major simplification of the morphological colony 
types(a reduction from 1 2 ^1  different colony types before treatment to only 
3 ^ 1  colony types for the same mice after 3 days treatment). The stability of 
the TVC may have been due to an increase in the numbers of the remaining 
anaerobic flora in the gut. An increase in the concentration of 6-aspgly
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(results Fig. 24) was also seen, but the concentration was lower than in faecal 
pellets of mice treated with TDD antibiotics or PTA. Again this can not be 
explained in terms of TVC as described above.
Surprisingly, there was some recovery of some of the anaerobic faecal 
flora (mainly gram negative rods) during treatment with CTX alone: an 
increase to 5 -f 1 colony types was observed by day 3 of treatment. A full 
recovery of diversity was seen 2-3days after treatment. The recovery of the 
anaerobic faecal flora during treatment may have been due to an inactivation 
of CTX by enzymes, possibly induced by the drug. The results from a 
preliminary experiment (results section. 3.4.3.1) which involved the study of 
the concentration of CTX in mice caecum treated with 3 mg of CTX for one 
day or for four days supported this view. Following one dose, a zone of 
antimicrobial activity was seen around faecal pellets up to 20 hours after 
treatment. In a second experiment the highest concentration of CTX in the 
pellets was estimated as 20 fig g'1 of caecum contents 10 hours after 
treatment ( materials and methods. 2.13.3). However, in mice treated for 
four days (when an increased concentration was expected due to the 
accumulation of the drug) zones of inhibition were only seen 2 hours after 
treatment and the maximum estimated concentration was 1 f i gg '  of caecum 
contents.
Early studies demonstrated that CTX is resistant to a wide range of 
plasmid and chromosome-mediated B-lactamases (Carmine et al., 1983). 
However, subsequent studies showed that CTX is hydrolyzed by Klebsiella kl 
enzyme (type IVc) and the type Ic enzyme from Proteus vulgaris (Schrinner et 
al., 1984; Neu, 1987). Also CTX is hydrolyzed by 8-lactamases TEM-3,4 and 5, 
and SHV-2,3,4 and 5 (Jacoby and Carreras, 1990). In an in vivo study 
performed by Soriano etal., (1989) itwas reported that 8-lactamase activity of 
Bacteroides fragiiis may be responsible for the diminished activity of CTX in
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mice with mixed E.coli and Bacteroides fragilis infections.
Although, CTX is regarded as a drug of minimal value in the treatment 
of anaerobic infections, the drug has appreciable activity against certain 
species of anaerobes, particularly the anaerobic cocci (Carmine et al., 1983; 
Pollock et al., 1983; Jones et al., 1984; Conawati, 1989; Friis, 1989). This 
activity may be summarized as follows: The inhibitory values against 
Bacteroides fragilis as well as other Bacteroides varied widely and although 
most isolates are susceptible, the MIC value is usually < 4 gl'1. Most isolates
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of Clostridium perfringens are inhibited by < 4 g l1, but many isolates of 
Clostridium difficile are resistant. In addition, cefotaxime is also active against 
Veillonella spp., propionibacteria, peptococci, peptostreptococci, and 
Bifidobacterium spp..
Broadly speaking the pattern of simplification of anaerobic flora which 
we observed (results Fig. 5 and 9) could be partly explained in terms of this 
pattern of activity. However, it appears possible that there were additional 
effects that can not be readily be explained by the observed pattern of in vitro 
activity. This is a complex issue that deserves further detailed investigation.
The addition of systemic cefotaxime to PTA antibiotics was associated 
with striking additional effects on the intestinal flora of mice. As with PTA 
alone or CTX alone E. coli was eliminated after one dose of treatment and had 
not reappeared two weeks after cessation of treatment. However, this effect 
was accompanied by a marked increase by 2.6 +_ 0.4 log (cfu) in the total 
count of enterococci during treatment. The increase was reversed to the 
normal level 7 days after stopping treatment.
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Striking additional effects on the anaerobic faecal flora were also seen. 
Unlike either PTA or CTX used alone, the anaerobic TVC was reduced to non 
detectable levels in 50 % of mice. In the 50 % of mice where the anaerobic 
flora was retained, the TVC was reduced by 1 log and only 1 - 2 colony types 
were seen during treatment. These bacteriological findings were supported 
by the results of B-aspgly. The concentration of B-aspgly had increased 
during treatment with PTA plus CTX (result Fig. 25), and the level of 
concentration of B-aspgly in mouse faecal pellets was much higher than in 
mice treated with PTA alone or CTX alone.
Viewing this pattern of results, it is highly unlikely that the striking effect 
seen with PTA plus CTX could have been predicted from the very modest 
effect seen with PTA or CTX alone. Therefore there appears to have been a 
synergistic interaction which produced wholly unexpected results. It is 
extremely difficult to hypothesize about the nature of such interaction in the 
highly complex environment of the intestine.
This marked reduction in the TVC and the simplification of the 
anaerobic faecal flora during treatment with PTA combined with CTX were 
very surprising results it terms of the clinical application. The clinical 
application of PTA has almost invariably involved CTX and the suggestion of 
this work is that this combination may be associated with flora changes that 
may result in a major impairment of CR.
4.5 The Effect Of SDD Regimen OnCR:
Different groups of 8 mice were treated with PTA (polymyxin, 
tobramycin, and amphotericin B) SDD drugs, and challenged with different 
doses of Proteus mirabilis s-R9. As already discussed, it was necessary to use 
different challenge strain from that used in TDD experiments.
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It proved impossible to colonize control mice with an oral challenge of 
10 log (cfu) of Proteus mirabilis s-R9. In contrast, after 5 days treatment with 
PTA alone theCR fell to 8 and this value was retained throughout a maximum 
of 14 days treatment. Overgrowth of Proteus mirabilis s-R9 in the gut did not 
occur - the TVC never exceeded 6.8 + 0.3 log (cfu) /  gram of faeces after 
challenge. This level of TVC was below the challenge level and it dropped to 4 
+ 0.2 log (cfu) / gram of faeces 5 days after stopping treatment. SDD thus 
resembled TDD in producing a measurable reduction in CR but differed in that 
the effect was very much smaller and that the gut environment prevented 
extensive multiplication of the challenge organism.
This small reduction in the CR during treatment with PTA may have 
been due to the discussed simplification of the anaerobic flora, the 
elimination of E.coii from the gut, or the activity of SDD drugs on the 
challenge organism. Although the Proteus mirabifis s-R9 was resistant to high 
levels of the SDD drugs (material and methods. 2.3), there might have been 
sufficient activity to impair its growth in the faecal environment. The highest 
activity of SDD drugs were seen at 8 hours after treatment which might had 
small residual effect on Proteus mirabilis s-R9. Unfortunately faecal pellets 
studies were not done.
To summarize CR may have been reduced by the apparent elimination 
of E.coli, the simplification of anaerobic flora and a possible residual effect of 
the SDD drugs on the apparently resistant challenge strain. Conversely, this 
effect may have been minimized by the maintained levels of enterococci and 
the maintenance of the over all levels of anaerobic TVC. The problem of 
interpretation here well illustrates the complexities of this experimental 
system. Oversimplified conclusions should not be drawn and experiments to 
discriminate between these various interactive effects in in vivo systems are 
difficult to design.
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In an attempt to further investigate the role of the aerobic faecal flora 
on the CR, we treated mice with clindamycin. As planned the anaerobic flora 
was severely affected; after one dose of treatment they were not detected in 
the faeces. The recovery of the anaerobic flora after stopping treatment was 
slow; by day 5 only 5 + 1 colony types were seen compared to 12jH 1 colony 
types for the mice before treatment. Similar results were reported by Nord et 
al., (1978) in humans. Unfortunately, the aerobic flora was also significantly 
disturbed. The TVC of E.coli greatly increased (by 3.5 +0.6  log cfu) and levels 
of enterococci were reduced to a non-detectable level during treatment.
The CR in mice treated with clindamycin was severely impaired. This 
may have been due to the elimination of the anaerobic flora by clindamycin, but 
the apparent elimination of enterococci can not be ignored. Certainly the 
increased levels of E.coli were inadequate to preserve CR. This result along 
with the findings from TDD and SDD experiments is compatible with the 
assumed important role of the anaerobic flora in maintaining theCR.
The CR in mice for Proteus mirabilis s-R9 immediately after stopping 
treatment and 7 days after treatment with SDD regimen varied depending on 
the duration of SDD treatment. The CR in mice treated for 5 days with SDD 
antibiotics was 8, which is similar to that during treatment, where as in mice 
treated for 10 days the CR was 7. These are results of a single experiments 
which showed that the longer the treatment period, the greater the residual 
effect on CR. However, flora studies did not show corresponding affects where 
there was almost a complete recovery of anaerobic flora at that time. As these 
were a result of a single experiment this area requires futher investigation.
TheCR in mice during treatment with cefotaxime alone was not studied 
as the challenge organism Proteus mirabilis s-R9 was sensitive to cefotaxime. 
However, the CR in mice for Proteus mirabilis s-R9 one day after completion of
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treatment with cefotaxime alone exceeded the maximum challenge 9.2 log 
(cfu). Atthistime, faecal pellets showed no antimicrobial activity.
This maintenance of CR was unsurprising in view of the small change 
seen in overall anaerobic TVC. However, there was amajor simplification in the 
anaerobic flora in these mice, and the maintenance of CR in these 
circumstances suggests that such changes do not necessary result in a 
reduction in CR. This maintenance also may had been due to the very fast 
recovery of the anaerobic flora by day 3 of treatment and immediately after 
stopping treatment (results section. 3.2.3.S), compared to the recovery of 
normal flora in mice treated with PTA regimen alone.
A striking effect on CR was observed when CTX was used in conjunction 
with PTA. Challenge one day after stopping cefotaxime showed marked 
decrease in the CR to < 4  (the lowest challenge dose tested was 4.4 log (cfu)). 
This marked impairment in CR compared to control mice (10) or to mice 
treated with SDD alone (8) parallels the marked effect of SDD and CTX on gut 
anaerobic flora. (The anaerobic flora in mice during treatment with PTA 
regimen combined with cefotaxime was almost identical to that of in mice 
treated with TDD antibiotic).
We found these results are very surprising. PTA antibiotics combined 
with systemic cefotaxime have been extensively used clinically for over 8 years 
(Introduction Table. 3). During this time, there have been no reports of 
significant problems caused by colonization or overgrowth with organisms 
resistant to the drugs used. This implies maintenance of effective CR, and a 
corresponding maintenance of intestinal anaerobic flora has been assumed 
by the authors concerned. However, none of these studies included 
bacteriological data on faecal anaerobes, although enterococci were 
sometimes used as an indicator of anaerobe levels (a convenient but doubtful
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assumption). The major discrepancy between these clinical studies and the 
CR data described here may reflect anumber offactors:
1) A host difference (mice and men). A number of studies have suggested that 
the intestinal microflora of mice and humans appear to respond to 
antimicrobial agents in a similar fashion (van der Waaij, 1979; van der Waaij et 
al., 1982). However, the complexity of the systems and limitations of the 
technical procedures must limit the application of these conclusions.
2) A challenge strain effect. Only one strain of Proteus mirabilis was used in 
these experiments. Therefore this may be a result unique to this particular 
challenge strain in a particular strain of mice. In contrast, clinical studies refer to 
a much more complex situation. Again, it was unfortunate that we were unable 
to procure multiple challenge strains for the SDD experiments.
3) The use of drugs (tobramycin, polymyxin and cefotaxime) showing a very 
wide spectrum of activity, with overlap between their antimicrobial spectrum. 
The drugs were also bactericidal and used in very high local concentrations. In 
these circumstances it may be that the drugs were sufficient in themselves to 
prevent colonization with SDD resistant strains in patients, despite a significant 
reduction in CR. However, these considerations may be applied equally in the 
mouse model. Finally, even a resistant organism might not have the ability to 
establish itself and colonize the gut. Inastudy performed in mice, I was unable 
to colonize TDD mice with a high challenge dose of 10 log (cfu) of 
Pseudomonas cepacia (from human origin) entirely resistant to the TDD 
antibiotics.
4) The probable absence inpatients of an explicit oral challenge administered 
as a bolus of highly resistant organisms as used in the mouse model.
Despite these factors, the contradictory pattern of results remains 
disturbing. On one hand we have experimental data which suggest that the
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PTA and CTX regimen may be associated with a major reduction in CR, with a 
demonstrated colonization with drug resistant strains following oral challenge. 
On the other hand, we have 8 years of clinical usage of this SDD regimen which 
suggests that no such colonization takes place. Certainly our results indicate 
the need for considerable care in the clinical use of the PTA and CTX regimen 
and further reinforces the absolute requirement for detailed microbiological 
monitoring to allow early detection with drug resistant strains.
4.6 Conclusions:
In this study we first, repeated the total decontamination studies 
described by van der Waaij and colleagues between (1971-1974) in order to 
verify or modify their conclusions concerning the nature of CR. Secondly, we 
used the same mouse model to study the CR in mice treated with the SDD 
regimen that has been most commonly used in clinical ICU practice (PTA). 
Considerable problems were experienced in the preparation of challenge 
strains, particularly for the SDD experiments. Suitable challenge strains are a 
prerequisite for studies of this type. Despite considerable efforts we failed to 
solve many of the difficulties encountered in this area and further investigation 
is required.
Broadly speaking, our results support the concept of CR described by 
van der Waaij etal., (1971). We confirmed that the application of their technique 
allowed reproducible quantification of CR, that CR could be markedly reduced 
by TDD drugs, and that the recovery of CR after termination of TDD drugs was 
associated with recovery of faecal anaerobic flora. However, our results 
showed slow recovery of the anaerobic faecal flora after stopping treatment, 
with a corresponding delayed recovery in CR. This disagreed with van der
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Waaij et al.'s observation that CR had returned to normal within 14 days of 
stopping treatment. In addition, unlike van der Waaij, we observed a marked 
variation in the value of CR associated with different challenge strains. Further, 
the precise detail of experimental technique exerted a major influence on the 
results obtained. It was thus apparent that the phenomenon of CR reflects 
more complex mechanisms than those described by van der Waaij.
Results of SDD studies provided the first detailed data of the effect on CR 
of the PTA SDD regimen with and without the addition of systemic cefotaxime. 
PTA alone showed a small but significant reduction in CR whilst cefotaxime 
alone produced no significant effect on CR. However, striking and surprising 
results were seen in mice treated with PTA and cefotaxime. A marked reduction 
or simplification of the anaerobic faecal flora and overgrowth of enterococci 
was observed and this was associated with a marked reduction in CR. These 
results of the combined regimen were only partly compatible with a summation 
of the effects observed when PTA and cefotaxime were used separately. It 
seems that some form of synergistic interaction may have occurred by an as 
yet unexplained mechanism.
These results are surprising in view of the absence of drug-resistance 
problems associated with this widely used clinical regimen. They indicate the 
need for considerable care in the clinical use of the PTA and cefotaxime 
regimen, and further reinforce the absolute requirement for detailed 
microbiological monitoring to allow early detection of colonization with drug 
resistant strains. More generally, they establish the need for further 
experimental studies to supplement the numerous clinical trials in this complex 
area.
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Future, lines of research should further examine the effect of SDD and 
cefotaxime on aerobic and anaerobic faecal flora and on CR using mice and, if 
possible human models. In addition, extension of the present SDD data to 
include challenge with different bacterial species must be an early priority.
4.7 Addendum:
The origins of the concept of Colonization Resistance can be traced to 
the work of Nissle in 1916, whilst clinicians have attempted to modulate 
intestinal flora since the work of Garlock and Seley in 1939. Selective 
decontamination regimen, first used clinically by Guiot and van Furth in 1977, 
explicitly combine these two strands of work, aims to remove potentially 
pathogenic flora whilst retaining CR thus preventing overgrowth or colonization 
with drug resistant strains.
These results presented in this Thesis showed a reduction in CR whenever 
antibiotics were administered to mice (although the size of this effect varied 
markedly with the regimen used). Some reduction of CR during the clinical use 
of SDD may also be inferred from the described outgrowth or colonization with 
enterococci and coagulase-negativestaphylococci (Preheim etal., 1987 and 
Vandenbroucke-Grauls et al., 1991).
These findings suggest that it may be impossible to modulate gut 
microbial flora with antibiotics without changing the gut CR. An ideal SDD 
regimen may be unattainable. Lowering of CR during SDD may be associated 
with a reduction of components of the gut flora that contribute to CR and are not 
intentionally targeted by the antibiotic regimen. Alternatively, the organisms 
targeted by SDD (primarily AGNB) may themselves materially contribute to CR.
In the present study, flora changes other than those intended by SDD 
were indicated by the observed simplification of the anaerobic gut flora during 
treatment. As the methods used to detect this simplification were crude, it is 
probable that undetected changes in the strains of dominant organisms and in 
the minor components of the flora also occurred.There was no direct evidence 
from my experiments that AGNB (the targets of SDD) contributed to CR. 
However, the experimental design did not directly address this issue.
If some reduction of CR is an inevitable result of SDD, then this must be 
matched with the observed lack of problems associated with drug resistance 
that characterized ten years clinical use of SDD regimens. It seems highly likely 
that factors other than CR alone are involved. These probably include the very 
high gut level of decontaminating antibiotics (many times higher than attainable 
serum concentrations), and the very low likelehood of thee emergence of 
simultaneous resistance to the combinations of the drugs used.
The final emphasis must centre on the great complexity of this field 
andthe challenge that it continues to present.
APPENDICES
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Appendix 1
Media: Medium 10 (M 10; Caldwell and Bryant, 1966).
Composition of Medium 10 (M 10 Agar):
Trypticase (BBL) 2g
Yeast extract (Difco) 0.5 g
Agar(Difco) 15g
Glucose 0.5 g
Cellobiose 0.5 g
Starch 0.5 g
Mineral sol. 1a 37.5 ml
Mineral sol. 2b 37.5 ml
VFA sol.c 3.1 ml
10% Antifoam sol. 5 ml
0.1 %Resazurinsol. 1 ml
0.1 % Hemin sol. 1 ml
Cystiene. HCI.H O 0.5g
Ascorbic acid 0.5 g
a. Mineral sol. 1 (per litre): K HPO^, 7.8 g.
b. Mineral sol. 2 (per litre): KH PO , 4.7 g; (NH ) SO , 12 g; CaCI , 1.2 g;
  2 4  4 2 4 2
MgSO .7H 0 ,2 .5g .
c. Volatile fatty acid mixture: acetic, 17 ml (2.9 x 102 M); propionic, 6 ml (8.0 x 
10'3 M); butyric, 4 ml (4.3 x 103 M); isobutyric, 1 ml (1.1 x 103 M); N-valeric, 
isovaleric, and DL-alpha-methylbutyric, 1 ml each (9 x 104 M).
() indicate thefinal concentration in 1000 ml medium.
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Appendix 2
Participation in Congresses:
A 2-1 Selective Decontamination of the Gut: effect of Oral Antibiotics on
Colonization by Gram-Negative aerobes in Mice. A. S. Ameen, A. B. J. 
Speekenbrink, S. R. Alcock. Society for General Microbiology 11&h Meeting, 
Warwick, April 1990, Abstract No. 1415, p.53.
Infection is a major problem in intensive care units (ICU) and in the 
management of neutropaenia. A high proportion of infections in these 
vulnerable patients groups are though to be endogenous with aerobic gram- 
negative bacilli (AGNB) colonizing the oropharynx, stomach and intestines are 
the principle source of infection. Selective decontamination of the digestive 
tract (SDD) has been employed for infection prophylaxis in neutropaenia since 
1977 and has been increasingly applied ti ICU patients since 1984. SDD 
employs non-absorbable antibiotics to eliminate or markedly reduce the 
numbers of AGNB and of yeasts in the gastrointestinal tract, thus reducing the 
risk of endogenous infection, whilst retaining the normal anaerobic flora, thus 
preventing colonization or overgrowth with drug-resistant strains. This 
protective action of the anaerobic flora is of central importance to the clinical 
use of SDD regimen and it is one manifestation of a more general phenomenon 
termed colonization resistance (CR). This concept has attracted considerable 
controversy. The experimental basis for the concept of CR is dependent to a 
surprising degree on a series of studies performed in 1971-1972 by van der 
Waaig et al., (1971; 1972), and involving total rather than selective 
decontamination of the digestive tract. Problems arising during our 
experimental work suggested that we repeat these early studies. We 
challenged mice with E.coli before, during and after decontamination using 
streptomycin and neomycin, and we confirmed the results of the original 
studies. (We present our results and discuss their significance).
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A 2-2 Reduction of Colonization Resistance in Balb / c mice. A. S.
Ameen, A. B. J. Speekenbrink, S. R. Alcock. 91st General Meeting of the 
American Society for Microbiology, Dallas, May 1991, abstract No. 251, p. 113.
Selective decontamination of the digestive tract (SDD) uses antibiotics to 
reduce aerobic gram-negative rods, thus preventing endogenous infection with 
these organisms. Retention of the predominant anaerobic flora is thought to 
prevent colonization with strains resistant to the SDD agents (colonization 
resistance (CR)). The mechanisms underlying the observed clinical success of 
these regimens remain contentious. A clinical regimen of tobramycin and 
polymyxin E was used for SDD in Balb / c mice. Other mice were given 
streptomycin and neomycin for the elimination of aerobic and anaerobic flora 
(total decontamination (TDD)). Oral challenge of 108'10 E.coli was required to 
achieve intestinal colonization of untreated mice. This finding was species 
specific in that colonization of untreated mice with Proteus sp., Pseudomonas 
aeruginosa and Klebsiella pneumoniae was impossible at doses of 10“ 10 cfu. A 
marked reduction in CR was seen following total decontamination: < 102 cfu of 
E.coli achieved colonization in 16/16 mice following oral challenge both during 
and one day after discontinuation of TDD. Contrary to previous reports a small 
but significant reduction in CR to Proteus sp. was also seen in 7 / 8 SDD mice 
which showed no evidence of reduction in intestinal anaerobic flora.
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A 2-3 Selective Decontamination of the Digestive Tract (SDD) and
Colonization Resistance (CR) in Mice. A. S. Ameen, A. B. J. Speekenbrink, S. 
R. Alcock. 92nd General Meeting of the American Society for Microbiology, New 
Orleans, May 1992, Abstract No. 366, p. 87.
SDD uses antibiotics to reduce the number of aerobic gram-negative 
rods colonizing the digestive tract, thus preventing endogenous infection with 
these organisms. SDD also prevents colonization with drug-resistant strains 
by retaining the anaerobes of the tract; this is known as CR. Balb / c mice were 
given a clinical SDD regimen of oral streptomycin cefotaxime (CTX). 
Alternatively, a regimen of oral streptomycin and neomycin achieved total 
decontamination of the digestive tract (TDD). Intestinal colonization of 
untreated mice with E.co// required an oral challenge of 1081° cfu. In TDD mice 
there was major impairment of CR: a challenge dose of 102 cfu of E.coli, 
administered during and 1 day after treatment, colonized 36 / 36 mice. In SDD 
mice, a small but significant reduction in CR was seen: over 50 % of mice 
challenged during treatment with 108 cfu of Proteus strain were colonized, 
whereas it was impossible to colonize untreated mice with a challenge dose > 
101° cfu. Although CTX alone did not impair CR, a marked reduction in CR 
occurred during treatment with SDD and parenteral CTX: 24 / 24 mice were 
colonized when challenged with 104 cfu of the proteus strain. Simplification of 
the anaerobic intestinal flora was also observed with the regimen of SDD and 
parenteral CTX.
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